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Chapter I 
INTRODUCTION 
I. I Rationale 
Cardiovascular diseases are the leading cause of mortality in the industrial-
ized world. together accounting for about one-half of the total number of annual 
deaths. Coronary heart disease comprises about one·half of the cardiovascular 
mortality and cerebrovascular disease about one-quarter. Diseases of the circu-
lation not only result in many lost years of life. but they also compromise the 
quality of life considerably. 
The main cause of cardiovascular diseases is atherosclerosis. Many factors 
are implicated in atherogenesis. but serum lipids and especially serum cholesterol 
appear to play an essential role. In biochemical studies cholesterol was found 
to be the principal lipid ingredient of the atherosclerotic lesion.,.. In animal 
experiments it was shown that feeding cholesterol was necessary to produce 
major atherosclerotic lesions 5 ·6 Clinical studies showed that patients with coro-
nary heart disease had higher serum cholesterol concentrations than those free 
of this disease.7•8 Epidemiological investigations revealed positive relations be-
tween serum cholesterol levels and the prevalence and incidence of coronary 
hean disease in both cross-sectional and longitudinal studies.9-13 
Subsequently. various fractions of serum total cholesterol. carried in the 
blood by different lipoproteins. 14·15 were studied. New clinical and epidemio-
logical studies were carried out to find the relevance of these lipid fractions 
as indicators or predictors of coronary heart disease. Once the positive relation 
between total cholesterol and coronary heart disease was established. emphasis 
was laid on high density lipoprotein (HDL) cholesterol as a possible protective 
factor. Although this protective relation had been suggested in the early fif-
ties.16 it was not until the mid seventies that by a publication of Miller and 
Miller. 17 the discussion revived. In the mean time low density lipoprotein (LDL) 
cholesterol was proposed as the main atherogenic factor. 18 Some investigators 
suggested that not LDL or HDL cholesterol. but rather their ratio. was the most 
important predictor of coronary heart disease.19 More recently apolipoproteins. 
molecular protein structures on the surface of the lipoproteins. have been sug-
gested to be even better predictors of coronary heart disease.10 
II 
Atherosclerosis does not only affect adults. Rather. evidence is accumulating 
that atherogenesis begins in childhood. Post mortem studies have shown aortic 
atherosclerotic lesions in children21 and coronary lesions in young soldiers killed 
in Korea and Vietnam22·23 Aortic fatty streaks are present in virtually all child-
ren over the age of 3 years and by the age of 20 years many have coronary 
fatty streaks. 2 1.24 Although early atherosclerotic lesions are ubiquitous in child-
ren. the incidence of coronary heart disease is not the same all over the 
world.25 The early fatty streaks may transform to fibrous plaques or progress 
into advanced atherosclerotic Jesions.26 Eventually. this may be brought about 
as one of the manifestations of coronary heart disease. notably angina pectoris. 
myocardial infarction or sudden death. As the process of atherosclerosis begins 
early in life. it may have merit to study its aetiology. pathogenesis and distri-
bution in the young. An increase in knowledge about the aetiology and early 
determinants of cardiovascular diseases may prnvide more specific tools for early 
preventive activities. From studies in adults risk factors for coronary heart dis-
ease have been identified. notably blood pressure. serum lipids and cigarette 
smoking. The findings in a recently reported pediatric autopsy study suggest 
that childhood levels of risk factors for cardiovascular diseases may be related 
to even the earliest stages of atherosclerotic lesions in youth. 27 In this study. 
significant associations were observed between the percentage of fatty streak 
involvement of the aorta and previously measured total and LDL cholesterol. 
whereas VLDL cholesterol was related to coronary artery fatty streaks. Other 
studies of childhood risk factors and end-organ damage have supported the view 
that early in life risk factors are related to atherosclerosis. and that cardiovas-
cular disease begin in childhood.::8 .29 These observations provide the additional 
rationale for investigations of serum lipids in the young. 
1.2 Study objectives 
Several questions may be asked concerning serum lipids early in life. A first 
question is: what are the distributions of serum lipids in children and young 
adults and what determines the level? A question to follow naturally is whether 
there is any relation between serum lipid levels early in life and later on. A 
confinnative answer to this question is a prerequisite for prediction of future 
cholesterol levels and research into the aetiology of hypercholesterolemia. by 
12 
inquiries of patterns and determinants of change of lipid levels. 
A next question is whether heart disease can be prevented by favourably 
modifying risk factor levels in children. Preventive actions should be based on 
a joint understanding of the aetiological concepts of chronic diseases and the 
theoretical aspects of prevention. A final question is whether it is possible to 
predict heart disease by measuring serum lipid levels early in life. This is not 
only important in finding high risk persons for preventive intervention. but it 
may also lead to new insights into early atherogenesis. 
1.3 Chapter outline 
The above mentioned questions led to study objectives that were investigated 
using several study designs and data analytical approaches. This is described in 
chapter 2. which also gives a description of the study population and measure-
ments. In chapter 3. the distributions of total and HDL cholesterol in childten 
and young adults are given (appendix 1). Determinants which are discussed in-
clude familial aggregation. anthropometrical variables. hormonal factors and life 
habits (appendices 1-4). The natural history of serum lipids is described in chap-
ter 4. It includes prediction of future levels and patterns and determinants of 
change (appenilix 5). 
Chapter 5 gives a short introduction of lipid metabolis!J1 and atherosclerosis 
as a cellular proces. It continues with a discussion of the possiblities of preven-
tion by introducing a hypothetical model of the relation· between either level 
or change of serum cholesterol. and the risk of coronary heart ilisease. Such a 
model may serve as a rationale for either the whole-population or the high-risk 
approach of preventive actions. Finally. some aspects of the early prediction of 
coronary atherosclerosis are discussed (appendix 6). 
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Chapter 2 
METHODOLOGY 
2.1 General 
In epidemiology there are two major types of research: observational and 
experimental studies. 1 To establish cause-effect relationships. the experiment 
with randomization on the basic element in study design. serves as the ·gold 
standard·.:! However. it is not always possible to perform experimental studies 
and therefore observational studies may have their own merits. provided that 
care has been taken to avoid bias in the design of the study or. when possi-
ble. to control bias in the analysis. The types of study described in this thesis 
are ali observational in character and they include cross-sectional. follow-up 
and case-control studies. In table 2.1 the several study objectives of this thesis 
are summarized by type of study. 
TABLE 2.1 
Studies of serum lipids in young people reported in this thesis 
!Y£! Stud;( obiectives chaete:r Aooendix 
Cross-sectional Distributions of serum lipids 3 1 
Determinants of serum lipids 
familial aggregation 3 1 
anthropometrical va:dables 3 1 
hormonal factors 3 1,2 ,3 
life habits 3 1 
Follow-up Determinants of serum lipids 
hormonal factors 3 2,3,4 
Natural history of serum lipids 4 5 
Case-control Early prediction of atherosclerosis 5 6 
2.2 Study population 
The study subjects described in this thesis actually derive from three diffe-
rent populations. including one general population and two hospital populations. 
2.2.1 General population 
In 1975 a large cross-sectional study on determinants of various chronic di-
seases including rheumatic disorders. chronic non specific lung disease. urinary 
tract infections and cardiovascular diseases was initiated by professor H.A. Val-
17 
kenburg in Zoetermeer. a suburban town near The Hague (the EPOZ study. Epi-
demiologic Preventive Organisation Zoetermeer).3 Two districts in Zoetermeer 
(which doubled in number of residents from about 40.000 in 1975 to about 80.000 
in 1985) were chosen for this study. an urban and a rural one. From the 13.462 
subjects eligible. 10.532 participated (78.2 %) in the baseline survey. In the group 
of 5-30 year olds. 5.367 subjects out of 6.672 eligible (80.4 % ), were examined. 
Although it was cross-sectional in nature. the EPOZ study served as a starting 
point for follow-up studies. 
A follow-up study on risk factors for cardiovascular diseases was initiated 
in those originally 5-19 years old. From the 4.649 (out of 5.670. 82.0 %) subjects 
in this age group who took part in the study. 1.615 were selected for yearly 
follow-up. 4 They were selected if they had a risk factor level that was above 
the upper decile of the age and sex specific distribution of blood pressure. serum 
cholesterol. body mass index or smoking habits. A control group was selected 
at random from the remainder of the 5-19 year olds. 
From the 1.615 subjects selected for yearly follow-up a subsample could be 
constituted which represented a random sample of the original population. It 
comprised 596 yougsters (296 females) and it will be referred to in several ana-
lyses in this thesis. 
Because the EPOZ study was designed as a family study. risk factor levels 
of the parents of the study children were also available. 
As the initial examination took place between 1975 and 1979. the maximum 
follow-up period for an individual who entered the study in 1975, was 10 years 
and for those who entered in 1979. 6 years. 
2.2.2 Hospital population 
The studies described in appendices 4 and 6 are based on hospital popula-
tions from the Zuiderziekenhuis hospital in Rotterdam (Department of Cardio-
logy). the Juliana Children's hospital in The Hague and the Universi'5' hospital 
in l..eiden (Department of Pediatrics). 
Zuiderziekt:nhuis hospital All male patients under the age of 60, who were 
referred to the Zuiderziekenhuis hospital for a first coronary angiography to 
evaluate angina pectoris in the period from August 1983 to February 1985. were 
eligible for the study on early prediction of atherosclerosis (as described in 
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appendix 6). Two groups of patients were selected on the basis of an angiogram: 
(1) those with no coronary atherosclerosis (less than 20% stenosis). and (2) those 
with severe coronary atherosclerosis (at least 3 ;ressels with over 70% stenosis). 
Excluded from the study were patients who had no children. suffered from dia-
betes mellitus. hypertension (defined as at least one year of treatment with 
anti-hypertensive drugs). had lipid lowering medication. or were known to have 
cardiomyopathy or valvular defects. Twenty-nine men with no coronary sclerosis 
and 35 men with severe coronary sclerosis were selected for the study~ and 
their families. including their youngest son and/or daughter. were invited to 
participate. The response rate was 92%. Twenty-seven families with 23 sons and 
14 daughters. of whom the father was free of coronary atherosclerosis. and 32 
families. with 29 sons and 14 daughters. of whom the father suffered from severe 
atherosclerosis. were examined. The age distribution in the two groups of child-
ren was very similar and ranged from 6-36 years. with a mean age of 21.2 years. 
Juliana Children ·s hospital and University hospital Lei den In the outpatient 
clinics of these hospitals extremely tall prepubertal girls were treated with high 
doses of estrogens in an attempt to increase their rate of bone maturation and 
so to reduce their final adult height. In the period between november 1978 and 
februari 1980 there were seventeen girls. aged 10 to 14 years. who attended 
these clinics. Fasting blood samples were taken from them at the start and at 
the end of a period. that ranged from 4 to 17 months. to study the effect of 
large doses of ethinylestradiol on lipid levels. A reference group of age-matched 
girls was selected from the EPOZ study. 
2.3 Measurements 
For each yearly examination in the EPOZ study the subjects visited the study 
centre in Zoetermeer. Those 10 years and older completed a questionnaire about 
smoking habits. physical activity. and the use of alcohol and coffee. Data on 
smoking habits included a question on the average number of cigarettes smoked 
daily. A physical activity score was based on questions about regular sports 
activities. including membership in sports clubs. daily bicycling and walking. 
Questions were asked about the average number of cups of coffee consumed 
daily. The frequency of alcohol consumption was assessed in three categories: 
none. occasionally and daily consumption. As the question on alcohol intake 
19 
was introduced later in the study. we did not obtain data on alcohol consumption 
for all subjects from the start of the study. Females were also asked about their 
menstrual history. pregnancy and current use of oral contraceptives. Later on 
in the study this part of the questionnaire was extended with questions on num-
ber of pregnancies. brands of oral contraceptives used and the duration of their 
use. To refresh a womans memory a box with samples was used. 
Blood pressure was measured with a random zero sphygmomanometer after at 
least 15 minutes of rest. Body height (in em) and weight (in kg) were measured 
with the subjects wearing indoor clothes and no shoes. The Quetelet index, the 
ratio of body weight over height squared. was used as an index of body mass. 
Blood was taken by venipuncture from the nonfasting subjects. Before leaving 
the studycentre each respondent was seen by a medical doctor to be informed 
about the course of the study and to be motivated to participate. During this 
talk some notes were made. which sometimes appeared to be of use later on in 
the data analyses (e.g .. duration of pregnancy. initiation of oral contraceptive 
use). Another method to increase the response rate over time was by making 
home visits to those who were not able to come to the studycentre. Participants 
who had moved outside the study area (i.e .. the two districts of Zoeterrneer) 
remained in principle in the study population and often received home visits. 
A few weeks after their visit to the studycentre a letter was sent to the 
respondents with the results of their examination. Because the study was set 
up as an observational study and because at the start there was little known 
about harmful effects of high levels of risk factors in childhood. no intervening 
actions were undertaken. However. when a participant maintained a blood pres-
sure or cholesterol level above the 95th percentile. he or she was advised to 
see the family doctor. who was informed about the study results. 
The determinations of total and HDL cholesterol were carried out in the 
laboratory of the department of Epidemiology and checked regularly from 1978 
onward by the WHO Regional Lipid Reference Centre in Prague (Dr. D.Grafnet-
ter). The measurements were within limits throughout the entire study period. 
For total cholesterol the laboratory also participated from !980 onward in a 
control program of a Dutch organisation. the KCA (Clinical Chemical Analysis). 
which led to certification in I 985. Serum total cholesterol was measured with 
an automated enzymatic method, utilizing the colour reactions according to Ka-
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geyama.~ HDL cholesterol was also measured using an automated enzymatic me-
thod with the Trinder colour reaction. 6 after precipitation with phosphotung-
state-Mg'+. This measurement was introduced later on in the study. by the end 
of 1979. and therefore fewer data are available on HDL cholesterol than on 
total cholesteroL All serum that was left over after chemical analyses was stored 
in well-closed tubes at -20°C. For the case-control study on the early predition 
of atherosclerosis new serum variables were determined in cooperation with the 
laboratory of the department of Biochemistry I (Dr. P.H.E. Groot). Triglycerides. 
LDL cholesterol. HDL2 and HDI; cholesterol. apolipoprotein A-1 and A-Il were 
determined in the laboratory of the department of Epidemiology. whereas apoli-
poprotein B was measured in the laboratory of the department of Biochemistry 
L Triglycerides and cholesterol subfractions were determined according tO enzy-
matic methods (Boehringer Peridochrom and Monotest. respectively) after pre-
cipitation with polyvinylsulfate for LDL cholesterol and Mn2+ -heparin and dex-
transulfate for HDL2 and HDL3 cholesteroL' Apolipoprotein A-1 and A-ll were 
determined by radial immunodiffusion8 against specific antiserum. Monospecific 
antisera against human apolipoprotein A-I and A-II were raised in goats (pro-
vided by Dr. L. Havekes. Gaubius Institute. Leiden) and sheep (Boehringer Mann-
heim). respectively. Total apolipoprotein B was measured by quantitative immu-
noelectrophoresis according to Laurel!. 9 as described elsewhere. 10 
Questionnaires. biomedical and laboratory measurements were coded on op-
tical reader forms and entered on file in the PDPII/44 computer of the depart-
ment of Epidemiology. 
2.4 Data analytic approach 
Mean values of total and HDL cholesterol were calculated by gender and 
age in one year intervals. The method of 3-year moving averages was used for 
graphical presentation of the data. The cholesterol concentrations for the 5th. 
50th and 95th percentiles of the distribution were assessed for males and fema-
les. in 5-year age categories. 
For cross-sectional comparisons of lipid levels average values by comparison 
group were calculated and Student's t-test was used to assess the statistical 
significance of differences between the groups. When comparisons between groups 
were based on longitudinal data. average changes in lipid levels were assessed 
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by group over the follow-up period concerned, and statistical significance of 
the difference between these changes was assessed with Student's t-test. with 
the appropriate standard errors. 
In the analyses frequently a multiple linear regression model was used, in 
which total or HDL cholesterol was the outcome variable, and indicator varia-
bles were used as the independent variables.ll·12 In this way average choles-
terol levels could be computed by different categories of the independent var-
iables. An independent variable could be divided in two categories, like users 
of oral contraceptives and non-users. or smokers and non-smokers, or in more 
than two categories. The latter was used when for example an independent var-
iable was divided into categories according to distribution quartiles. In that case 
three indicator variables (x1• ~· x3) were created and entered into the regres-
sion equation. The lowest quartile served as the reference category and was 
reflected in the model by the intercept. Indicator variables were set to 0 (not 
in this category) or I (in this category). Thus, the second quartile was reflected 
in x1 , the third in x, and the fourth in X,· The model equation was: 
y = a + b1.x1 + b2.x, + b3.x3 
Because each value of the independent variable belonged exclusively to one of 
the categories chosen. the equation for an individual with an independent var-
iable in the second quartile of the distribution was: y = a + b1.x1, and for indi-
viduals with an independent variable in the third and fourth quartile it was: 
y = a + b2.x, andy = a + b3.x3• respectively. ln this way. the regression coeffi-
cients in this mode] served as the difference between the reference category 
(first quartile) and the category under study. An example will illustrate this. 
To study the relation between body weight and serum cholesterol levels in 
5-14 years old girls, the distribution of weight in this age group was divided 
according to quartiles: 
quartile = < 33 kg 
quartile 2 33-50 kg 
quartile 3 = 50-59 kg 
quartile 4 > 59 kg 
The regression analysis yielded the following results: the intercept was 185 mg-
/ I 00 ml and the regression coefficients were: b1 = 2 mg/1 00 mi. b2 = -2 mg/ 100 
mi. and b3 = -5 mg/100 mi. This resulted in the following average cholesterol 
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levels per quartile of body weight: 
quartile = 185 mg/100 ml 
quanile 2 = 187 mg/100 ml 
quani!e 3 183 mgllOO ml 
quartile 4 = 180 mgllOO ml 
To adjust for possible confounding factors, e.g, age. the regression coeffi-
cient of this confounding factor was multiplied with the average level of the 
confounding factor. and this product was added up to the intercept, to result 
in the adjusted average level of cholesterol for the lowest quartile. The (adjust-
ed) regression coefficients were then added up to the (adjusted) intercept to 
give adjusted average cholesterol levels per quartile. Significance of the differ-
ence in cho1esterol 1evel between the first and one of the other quartiles was 
assessed by the ratio of the regression coefficient and its standard error. This 
amounted to a Z-statistic with a standard normal distribution. 
The methods used to describe and analyse the longitudinal data on the na-
tural history of serum total and HDL cholesterol in early life are given separa-
te1y in chapter 4. Distinction will be made between the question of prediction 
of future cholesterol levels and the question of the aetiology of high cholesterol 
levels and atherosclerosis. The issue of prediction is often referred to as 'track-
ing·. i.e .. does a child maintain its position in the distribution over time. Both 
tracking of the total population and tracking of extremes of the distribution 
will be discussed. Aetiological issues will be discussed in terms of the natural 
history of serum lipids, conceptualized as change of serum lipids over time. This 
concept will include patterns ('horse-racing'. slopes) and determinants of change. 
Most of the data presented in this thesis were analysed with the BMDP sta-
tistical program. 13 
2.5 Discussion 
Observational studies give rise to various methodological questions and some 
of these will be discussed below. 
First there is the question of the external validity of the study. Is it possible 
to generalize the results? The non-response rates varied from 13% in those 5-9 
years of age, to !6% in those 10-14 years and 23% in those 15-19 years of age. 
There is little reason to think that the non-responders in these age groups would 
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have had different levels of the risk factors. than the participants or that they 
would have shown other relationships between the determinants and risk factors. 
Therefore. we think it is justified to extend the conclusions from our study to 
all young people. 
A further concern is the internal validity of the study. Do our results deviate 
from reality. the true effect estimate? This question can be discussed in terms 
of the occurence of two types of bias: information bias and confounding bias. 
Information bias can be present in the fonn of misclassification of subjects, 
leading to random error in the determinant. However. this bias will give an un-
derestimation of the effect. rather than lead to a 'spurious' association. 
Confounding bias in follow-up studies may result from loss to follow-up and 
from differences at baseline. In a longitudinal study loss to follow-up may pro-
duce confounding when the cohort attrition is not randomly distributed over 
the participants. but is selective conditional on the study objectives. There were. 
however. no significant differences in initial blood pressure or serum cholesterol 
levels between those who stayed and those who were lost to follow-up in the 
EPOZ study. 
For assessing relationships between serum lipid levels and putative determi-
nants. data obtained in cross-sectional studies are widely used. However. caution 
should be exercised. and when possible cross-sectional relationships should be 
verified with longitudinal ones. The study of the relation between the use of 
oral contraceptives and serum cholesterol and blood pressure gives an illustration 
of this (appendix 2). Cross-sectionally. no differences were observed in total 
cholesterol or blood pressure between users of oral contraceptives and non-users. 
However. when changes in cholesterol and blood pressure over the two years 
of follow-up were taken into account. it was observed that women who were 
going to use oral contraceptives showed a larger increase in cholesterol and 
blood pressure than non-users. If this analysis had been the result of an exper-
imental study design (with random allocation of users and non-users) than the 
inference would have been much stronger. 
Another issue. inherent to a longitudinal study of the natural history of a 
variable. is the possible change in that variable caused by the study itself. As 
stated above. some participants were advised to see their family doctor when 
they had repeatedly elevated levels of blood pressure or cholesterol. However. 
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such a referral occurred only rarely and most of the time it concerned elevated 
blood pressure. 
The study design used to assess possible predicting factors for coronary heart 
disease by measuring serum lipids in children of patients who had had coronary 
angiography (appendix 6) is based on the following considerations. Measuring 
serum lipids in those who already have the disease (i.e .. coronary atherosclerosis) 
and comparing them with serum lipd levels in those free of the disease. may 
result in differences. that mainly are an epiphenomenon of the disease. In child-
ren. however. the disease. if already present. is much less outspoken. So. differ-
ences observed between the rwo groups of children are Jess likely to be the 
result of the disease. On the other hand. the lipid found to be the best discri-
minator berween the rwo groups does not need to be causally related to athero-
sclerosis. i.e .. it does not need to play a role in the atherogenetic pathway. 
Rather. it might be a marker for a metabolic defect that indirectly is related 
to atherosclerosis. 
A final methodologic issue concerns data-analysis. A linear regression model 
often was used to calculate average lipid levels by categories of the study deter-
minant. while controlling for possible confounding factors. The regression coeffi-
cient in the model served as the adjusted difference between the reference ca-
tegory and the study category. and the standard error of the regression coeffi-
cient served as the standard error of this difference. In this way the statistical 
significance of the adjusted difference could be assessed. using a standard normal 
distribution. To determine the standard error of the mean of the calculated ad-
justed average levels of the categories the most conservative way was chosen 
and the standard error of the unadjusted level was taken as the measure of 
variance. 
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Chapter 3 
DISTRIBUTIONS AND DETERMINANTS OF SERUM LIPIDS 
IN YOUNG PEOPLE 
3.1 General 
A first step in assessing associations of determinants and a study variable 
is a description of the distribution of that variable by age and gender. Age 
and gender are important determinants of total and HDL cholesterol and varia-
tions in their distributions may provide clues about other possible determinants. 
Differences in the level and distributions of serum lipids between different 
populations may yield insight into the reasons of these variations. This chapter 
therefore will start with a review of investigations of the level and 
distributions of total and HDL cholesterol in children and young adults in 
various populations. Thereafter. the evidence concerning the detenninants of 
serum lipids in early life will be discussed. notably familial aggregation. 
anthropometrical measurements. hormonal factors and life habits. 
3.2 Distributions 
Total cholesrerol Many investigators have studied serum cholesterol levels 
in children and young adults. A number of reviews has been published, in 
particular by Rafstedt until !955! by Hickie until 197427 and lately by 
Berenson. 65 However. a complete collection of aH studies on the distributions 
of serum cholesterol in childhood is not available. References 1-69 include 
practicaUy all studies on this subject in chronological order. Table 3.1 gives an 
overview of most of these studies with regard to number of study subjects and 
the average total cholesterol levels by age. One should be cautious in 
comparing cholesterol levels between the different populations. especially with 
regard to the older studies. because different analytic methods have been used. 
However. within populations average levels can be compared between the 
different age and race groups. A recent international comparison of 
cardiovascular risk factors in children from 15 countries has been described by 
Wynder.51 The data were restricted to 13 year old boys and average total 
cholesterol levels were compared between an but two countries. The highest 
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TABLE 3.1 
Total cholesterol levels from studies in children and young adults 
Population Age groups 
(years) 
Cholesterol 
(mg/100 ml) 
Males Females 
New York 3-7,8-12,13-17 
nor380 18-22,23-27 
Evans County, white 6,7,8, 
n=1,283 9,10,11 
12,13,14 
15,16,17 
non-white 6,7,8 
9,10,11 
12,13,14 
15,16,17 
180,180,176 
185,195 
158,163,170 
172,172,176 
175,184,185 
192,193,185 
137,151,157 
173,173,184 
175,175,185 
185,189,183 
Iowa 
n ... 9S2 
14-19 160 
Tecumseh 
n.,3,2.:.2 
20-24, 25-29 164,180 
4-9,10-14,15-19 177,172,166 
20-2~,25-29 195,214 
New York, Caucasian 10-13 
n=635 Chinese 
Negro 
Puer-to Rican 
Pretoria 
n-1,843 
Burlington 
n"'707 
7-11,12-15 
12,13,14. 
14,16,17 
169,161,157 
162,167,171 
160 
149 
155 
154 
209,196,183 
193,202 
156,164.,169 
168,170,171 
177,182,189 
191,194,179 
137,154.,159 
173,177,178 
187,177,196 
196,189,204 
173 
161,177 
178,176,173 
189,194 
219,207 
165,160,166 
169,168,176 
Mexico 
n-209 
Wisconsin 
n .. 328 
5-9,10-14 100,100 
Denmark 
n""l53 
California 
n.,.59 
Australia 
n-613 
Muscatine 
n-4,829 
Australia 
n-214 
Arizona 
nc2,249 
Denmark 
n-552 
5-9,10-14. 188,185 
6-10,11-15,16-20 194,201,196 216,206,220 
8-12 
11-18 
6-18 
11-19 
5-9,10-14 
15-19,20-24 
8-17 
179 
200 
180 
147,151 
150,173 
183 
182 
148,149 
159,177 
191 
Reference 
5 
9 
10,15 
11 
14 
16 
17 
21 
21 
23 
25 
27 
30 
32 
33 
34 
29 
Bogalusa, white 5,6,7 161' 168' 161 159,151,163 35 
ne3,446 8,9,10 162,166,163 168,167,162 
11,12,13 164,152,157 156,153,155 
14 151 158 
' 
black 5,6,7 170,170,170 165,179,170 
8,9,10 165,177,169 179,173,172 
11,12,13 171,173,160 174,164,168 
14 155 157 
Cincinnati, white 6-11,12-17 162,156 163,157 37 
n-6,775 black 6-11,12 167,161 171,165 
Norway 13-14115-16 175,170 179,184 39 
n-.404 
Rochester 6-10,11-14,15-18 159,156,153* 160,157,163* 40 
n-2,421 
LRCPPS white 0-19 155 159 48 
n=l3,655 black 0-19 162 157 
Israel 17-18 134 151 49 
n=2,565 
Finland rural 13-15 205 201 52 
n-967 urban 193 189 
Germany 12,13,14 182,178,171 185,177,170 53 
N•742 15,16 164,158 177,175 
Greece 10,11,12 153,155,151 155,157,151 54 
n=935 13,14 147,143 149,149 
Norway 11,12,13 205,202,194 206,204,191 55 
n=856 14 189 195 
Italy 11,12,13 154,147,149 155,155,151 55 
ne386 14,15 146,142 149,150 
Thailand 10,11,12 164,159,159 159,170,155 57 
nc1,090 13,14 167,163 177,176 
New York 12,13,14 159,155,148 162,158,157 58 
n"'3,662 15 147 157 
Netherlands 10,11,12 182,186,178 182,178,182 59 
n-1,016 13,14 174,162 170,174 
Nottingham 13,14,15 178,176,174** 184,193,178** 51 
n .. 625 16,17,18 167,170,170 189,189,203 
Switzerland, Swiss 8-9,14-15 189,170 192,181 52 
n-803 
Italian 8-9,14-15 178,170 185,177 52 
Italy 11,12,13 155,150,146** 150,156,149 .. 53 
n-644 14,15 144,143 155,156 
Israel, Israeli 7,11 153,148 !56,150 54 
n .. 808 European 154,155 164,157 
Asian 149,149 151,143 
N African 139,146 147,145 
Norway 11,12,13 186,184,178** 186,189,186** 56 
n=920 14,15,16 179,176,174 192,185,192 
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Beaver County 
n-561 
Finland 
n-3,596 
* median levels 
22, mean 
3,6,9,12 
15,18 
** extrapolated from graphs 
185 179 
183,191,191 186,198,196 
191,173,174 189,183,183 
68 
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average values were observed in Finland, followed by other northern European 
countries. in particular, Norway, West-Germany and the Netherlands. Nigeria, 
Italy. Greece and Japan showed the lowest cholesterol levels. In a recent 
report of Knuiman and Katan, 70 serum cholesterol levels in the Netherlands 
were found to be considerably higher than those in the United States. 
A striking finding when inspecting serum cholesterol distributions by age. is 
the "dip" in the average level from about age 9-10 years until the age of about 
16 years. In many studies this "dip" has been observed.5.I2.IS.l9.27.3s.37.3s. 
40
·
41.48 ·53 ·59 ·61.66·69 although in some others no relation of cholesterol with 
age has been found. 20 ·21.26 ·30·32 Another finding, which has often been 
reported, is the somewhat higher cholesterol levels in girls as compared to 
boys. 17 •23•37 ·39•40•48•61 In summary. serum total cholesterol values measured in 
the first two decades vary considerably between populations. and by gender 
and age. The age and gender differences were also observed in our data 
(appendix 1). 
HDL cholesterol Data on HDL cholesterol early in life are sparser than 
those on total cholesterol, but they still include a considerable number of 
in vest i gat ions. 36.40-47.49 .so .56.58 .60 .61.63·66.68 .69 Because international 
standardization programs for HDL cholesterol are much less developed than for 
total cholesterol. it is hard to compare average levels between different 
countries. Knuiman47 has studied total and HDL cholesterol levels in school 
children from !6 countries. Total and HDL cholesterol concentrations were 
determined in one laboratory to reduce methodological variability. Average HDL 
cholesterol levels appeared to be lower in countries with lower total 
cholesterol levels (the less developed countries). and higher in countries with 
relatively high levels of total cholesterol (the more developed countries). 
As with total cholesterol, in most studies differences by age and gender 
were observed in early adulthood. Until about the age of 16 years there is 
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little difference in HDL cholesterol between males and females. Males however. 
show a slight decrease from the age of !2 years. whereas females have a gra-
dual increase with age. and this results in a marked difference between men 
and women in their early twenties. 1t has been suggested that this observation 
may partly explain the greater occurrence of coronary heart disease in middle 
aged men compared to women.65 
In summary. HDL cholesterol levels show little variation between males and 
females until the age of about 16 years. Thereafter. females show markedly 
higher average levels than males. Our data (appendix I) largely confirm these 
observations. 
3.3 Determinants 
The determinants of serum lipids that have been investigated may be cate-
gorized as familial aggregation. anthropometrical variables. hormonal factors 
and life habits. 
3.3.1 Familial aggregation 
The familial aggregation of serum lipid levels has been well recognized. 
Both parent-offspring and sibling studies have been conducted4 .11.20·40 ·71 ·73 
and they have demonstrated consistently positive correlations for total cho-
lesterol levels between different family members. However. this does not allow 
definite conclusions concerning the question whether familial aggregation is 
due to sharing the same genes or sharing the same environment. Hames and 
Greenberg9 observed a correlation between blood group and serum total chole-
sterol levels in a preliminary analysis of children. aged 6-11 years. However. 
when they included children aged 12-17 years in the analysis. the correlation 
decreased in magnitude. They suggested that this might be due to the fact that 
when children grow older. environmental factors tend to dilute the mainly 
genetically determined differences observed at earlier ages. In our study 
(appendix !) we found parental cholesterol levels to be associated with total 
cholesterol in both children and young adults. 
3.3 .2 Anthropometrical variables 
Body weight and other indices of body mass. like Quetelet index and triceps 
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skinfold. have been investigated as detenninants of both total and HDL chole-
sterol. Most of the observed positive associations of body mass with total 
cholesterol were restricted to older age groups or male subjects. 11 •13·17• 
40
·
61
•
68
•
79 In younger age groups in general no association between anthropo-
metrical variables and total cholesterol was observect.1•9 .1°·11 .2? 3030 ·19 In 
contrast with total cholesterol. HDL choiestero] was found to be negatively 
associated with indices of body mass.40·42 ·44·45·60·79 especiaHy in males. In 
our study (appendix I). body weight and Quetelet index were positively related 
to total cholesterol in those 15 years and older. but not in the younger 
children. For HDL cholesterol body weight was a determinant in males older 
than 15 years of age. 
3.3.3 Hormonal factors 
Maturation has been implicated in the occurrence of the "dip" in total 
cholesterol between the ages of 10 and 16 years.'6•60•61 •66•79·80 ·81 and hor-
monal changes have been suggested to account for differences in cholesterol 
and its subfractions. Laskarzewski et al. reported associations between endo-
genous sex hormones and plasma lipids in adolescent boys. 82 Others however. 
were unable to find a correlation between change in sex hormones and change 
in plasma lipids during puberty in boys. 83 As the stage of maturation seems to 
play such an important role in determining the levels of serum lipids. the 
absence of a dip in a population study may well be the result of different 
stages of maturity within the same age-group. Longitudinal studies may there-
fore be preferred."' Besides. it has been suggested to include measurements of 
maturity stage in epidemiological studies of serum lipids. rather than- age. 66 In 
females. we did not observe a significant difference in total cholesterol levels 
between pre- and postmenarchal girls. However. we did find significantly 
higher HDL cholesterol levels in girls that had had menarche. than in those 
who had not (appendix 1). 
The role of exogenous sex hormones. notably oral contraceptives. in deter-
mining serum lipid levels has also been studied in young women. 45·60•85·88 The 
results. however. are equivocal and they largely depend on the age of women 
and the dose of estrogens and progestogens they were taking.89 In the 
cross-sectionaJ part of our study the use of oral contraceptives was positively 
33 
associated with total cholesterol levels, but no association with HDL 
cholesterol was observed (appendix 1). A longitudinal analysis (appendix 2) 
confirmed that women who started the use of oral contraceptives showed a 
larger increase in serum total cholesteroL over a two-year period, than women 
who did not use oral contraceptives. In a separate longitudinal study the effect 
of large doses of ethinylestradiol on lipid levels in excessively tall prepubertal 
girls was investigated (appendix 4). Girls. who were treated with hormones 
showed a considerably larger rise in total cholesterol than the agematched 
reference subjects. 
The increase in serum lipids during pregnancy is well recognized.90"92 and 
hormonal alterations have been implicated in this rise. A decline in lipid levels 
after pregnancy has been reported from several studies, but there is only 
limited evidence concerning the question whether lipid concentrations 
completely decline to pre-pregnancy levels. The investigation of Darmady ,93 
however. revealed a large individual variation in the time necessary to decline 
toward cholesterol and triglyceride levels before pregnancy. She found that 
mothers who breast-fed their children showed a more rapid fall in serum 
triglyceride, than mothers who bottle-fed their infants. In our study (appendix 
3) we could confirm the increase in serum total and HDL cholesterol in 
pregnant women, as compared to a matched non-pregnant reference series. 
Also, women in the third trimester of pregnancy showed higher levels than 
those in the first or second trimester. However. when cholesterol levels of 
women were compared the year before and the year after pregnany. it was 
observed that HDL cholesterol levels were significantly lower. in the year after 
pregnancy. 
3.3.4 Life habits 
Life habits that have been studied in relation to serum lipid levels in young 
people, include physical activity. the use of alcoholic beverages and cigarette 
smoking. Hickie et al. 27 observed higher total cholesterol levels in boys who 
were in the lower quartile of physical fitness as compared to boys who were in 
the top quartile. Physical activity and the use of alcoholic beverages have been 
shown to be positively related to HDL cholesterol. especially in adults.9 .. 96 
but also in adolescents. 61 ·68 Smoking in youngsters has been associated with 
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increased total cholesterol and decreased HDL cholesterol levels.44•60•61 •68 In 
our study we found that young men who consumed alcohol daily had higher 
total cholesterol levels than men who only drank alcohol occasionally. With 
regard to cigarette smoking we observed a weak association between this habit 
and total cholesterol in females (appendix 1). 
3.4 Concluding remarks 
Total and HDL cholesterol levels show marked differences by gender and 
age. Most pronounced is the 'dip' in total cholesterol for the ages 10-16 in 
both boys and girls. Another finding is the increase in total cholesterol from 
the age of 16 years onward. which is accompanied in boys with a decrease in 
HDL cholesteroL This difference early in life between males and females might 
partly explain the gender difference in coronary hean disease at later ages. 
From a preventive point of view it may be of impoltance that body weight in 
males is negatively associated with HDL cholesteroL The role of body weight 
as a determinant of total cholesterol is different for older and younger 
subjects. In those younger than 15 years other determinants are likely to be 
related to serum lipid levels. Investigations into factors that are related to 
physical maturation may yield other determinants of cholesterol concentrations 
early in life. 
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Chapter 4 
NATURAL HISTORY OF SERUM LIPIDS 
4.1 General 
Atherosclerosis is generally considered to be a life long process which begins 
early in life. Therefore. it may have merit to study the natural history of its 
risk factors in young people. The relationship between serum lipids and 
cardiovascular diseases is well established in adults. Thus. it is important to 
answer the question whether serum lipids in children relate to adult levels. This 
concept is often referred to as 'tracking'. Tracking may be defined as the ability 
to predict future lipid levels from earlier observations. or as the maintenance 
of the position of an individual in the distribution of lipids over time. In other 
words. if there is tracking of serum total cholesterol. it should be possible to 
detect future hypercholesterolemic subjects early in life. 
From an aetiological point of view. investigations of change and determi-
nants of change of serum lipids may yield new insights. In a longitudinal study 
of blood pressure it has been postulated that a person may be better 
characterized by the rate of change than by the actual level of a determinant. 1 
And Hames et a!.' suggested already in !961 that the rate of increase of blood 
lipids might be the key factor in atherosclerosis. A pattern of change which 
appears particularly interesting is 'horse-racing'. This refers to the situation 
where those with the highest inital level of a characteristic also experience 
the highest rate of increase over time. Another way to investigate change is 
to determine the slope. level and variability of serum cholesterol over time. 
and to relate it to putative determinants of change. 
4.2 Prediction of future levels 
Whether or not there is 'tracking' of serum total and HDL cholesterol can 
be assessed in various ways. In particular. one may consider the total population 
or only those in the extremes of the distribution. and one may use a single 
remeasurement or multiple rerneasurements. Because serum choJesterol values 
vary with age. it is preferable to transform the data to obtain age-adjusted 
values. Transformation into percentiles or z-scores. based upon the age- and 
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sex-specific distributions of total and HDL cholesterol, is easily performed. 
A z-score is determined by the following equation: 
z = (x - M) I sd. where x is the individual value. M the age- and sex-specific 
mean value. and sd the age- and sex-specific standard deviation of this mean 
value. 
4.2. I Tracking of the total population 
To assess the stability of a child's rank in the cholesterol distribution over 
time correlation coefficients between initial measurements and various follow-up 
examinations. expressed in either percentiles. or z-scores may be calculated in 
several age categories. separately for males and females. In this way. possible 
differences by age and gender are observed. In our study (appendix 5) we found 
that males showed higher correlation coefficients than females. for both total 
and HDL cholesterol. Overall. tracking coefficients for HDL cholesterol were 
somewhat lower than for total cholesterol. 
Other indices of tracking have been described by McMahan3 and Foulkes.' 
using different statistical models. 
4.2.2 Tracking of the extremes of the distribution 
In clinical practice. the main concern is with those who might be at risk. 
which means that their total cholesterol is 'high' or their HDL cholesterol is 
'low'. The interpretation of 'high' and 'low' depends on age- and sex-specific 
distributions of the serum Iipids. It is more or Jess arbitrary to define those 
with a 'high· cholesterol level to be above the upper quintile, decile, or whatever 
cutoff point of the distribution and the same holds for a 'low' HDL cholesterol 
leveL A key question is whether those in the extremes of the distribution keep 
their position over time. The concept of tracking applies equally to those in 
the extremes of the distribution as well as to the total population. but it may 
be useful to study the 'high-risk' and the 'total-population' approach separately. 
The methods that are described below may be divided in methods using a single 
remeasurement and methods using multiple remeasurements. If all values of total 
and HDL cholesterol are transformed into z-scores, it is possible to combine 
different age groups. 
When only one single remeasurement is taken into account. the main issue 
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is to find a measure for the probability of having an abnormal lipid level several 
years (time x') after the initial measurement (time x, see figure). 
A A' 
B B' 
time x time x· 
There are several ways to look at this 'high level' tracking. depending on the 
null hypothesis (H0). 
Consider. H0: 
the position in the distribution at time x' has no relation with the 
position in the distribution at time x. 
Example: suppose subjects in A are above the upper quintile of the distribution. 
Under the null hypothesis one fifth of those above the upper quintile of the 
distribution at time x (A) are to be expected above the upper fifth of the dis-
tribution at time x', so E(xpected)=l/5. If the observed proportion of A in A' 
is !15. then there is no relation with the place in the distribution. the obser-
ved/expected (0/E) ratio = I. If the proportion of A in A' is. say 2/5, then 
the 0/E ratio = 2. 
The 0/E ratio is a measure of high risk tracking. rather than a measure of 
the probability to keep a high rank order in the distribution over time. An 0/E 
ratio of 4 means that there are 4 times more people in A'. who originally were 
in A. than would have been expected if there had been no relation with the 
position in the distribution at time x. A disadvantage of the 0/E ratio is that 
its scale depends on the cutoff point. If the cutoff point is a quartile. the max-
imum 0/E ratio will be 4. if it is a decile. it will be 10. 
As A· will be composed of people coming from A (high level) as well as peo-
ple coming from B (normal level), it will be relevant to compare the proportion 
of A in A' with the proportion of B in A'. Therefore consider, H0: 
those with a high level at time x have the same probability of having 
a high level at time x'. as those with normal levels at time x. 
Example: the proportion of A in A' is 0.67 and of B in A' is 0.17. In other 
words. the probability for those at a high level at time A. to keep that high 
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level at time A' is 0.67 and they have a 3.9 times larger change to have a high 
level at time x'. than those with nonnal levels at time x. This socalled relative 
probability (RP) does not have a maximum value. like the OlE ratio and there 
is a simple relationship between them: 
O(A) OlE for A 
RP= ---= 
O(B) OlE for B 
The relative probability of having a high level at time x'. is the ratio of the 
OlE ratio for those having a high level at time x, and the OlE ratio for those 
with normal levels at time x. 
TABLE 4.1 
0/E ratio and RP for males and females related to the upper 
quintile of the distribution of total cholesterol 
sixth year of follow-up 
initial measurement proportion > 80% 0/E RP 
> 
< 
> 
< 
males 
80% n- 44 0.568 2.84 5.16 
80% n•l73 0.110 0.55 1 
females 
80% n• 37 0.459 2.30 3.45 
80% n ... 135 0.133 0.67 1 
TABLE 4.2 
0/E ratio and RP for males and females related to the lower 
quintile of the distribution of HDL cholesterol 
fifth year of follow-up 
initial measurement proportion < 20% 0/E RP 
males 
< 20% n• 46 0.514 2.57 4. 90 
> 20% n.o143 0.105 0.53 1 
females 
< 20% n• 27 0.370 1. 85 2.52 
> 20% n..:ll6 0.147 0. 74 1 
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ln our data we observed that the relative probability of being in the high 
level category at follow-up for those who had initially a high level, compared 
to those who had not, was larger for males than for females. This is in accor-
dance with the results concerning the total population. lt seems that in males 
there is a somewhat larger correlation between initial and final measurement of 
total and HDL cholesterol than in females (see table 4.1 and 4.2). 
When all remeasurements between the initia1 and final examination are to 
be taken into account, the following method may be used. The probability for 
having a "high· cholesterol at the ·n·th follow-up examination for subjects never 
having had a 'high· cholesterol can be compared with the probability of those 
who have been l, 2, . , .. n times above the upper quintile of the distribution. 
The relative probability for those who had a 'normal· cholesterol at each occa-
sion is set to L The same approach. but then for low levels. may be applied to 
HDL cholesteroL 
As expected. the relative probability of having a high level at the final ex-
amination increases with the number of times one has been in this high category 
of the distribution during previous measurements. For example. in our data. males 
who had 4 times (out of 6) total cholesterol levels that were above the upper 
males 
TABLE 4.3 
Absolute and relative probability of being above the upper 
guintile of the distribution of total cholesterol 
at the sixth year of follow-up 
probability of being above 
previous times above upper quintile at 6th year 
the upper quintile n absolute relative 
0 85 0. 059 1 
1 21 0.095 l. 61 
2 12 0.333 5.64 
3 8 0.125 2.12 
4 5 0.600 10.17 
5 10 0. 7 00 11.86 
6 9 0.889 15.07 
females 0 58 0.034 1 
1 19 0.053 1. 56 
2 13 0.308 9. 06 
3 16 0.375 11.03 
4 7 0. 714 21.00 
5 6 0.667 19.62 
6 3 1.000 29.41 
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TABLE 4. 4 
Absolute and relative probability of being bela~ the lower 
quin~ile of the distribution of HDL cholesterol 
at the fifth year of follow-up 
probability of being bela~ 
previous times bela~ lo~er quintile at 5th year 
the lower quintile n absolute relative 
males 0 81 0.037 1 
1 24 0.167 4.51 
2 15 0.458 12.38 
3 14 0.469 12.68 
4 7 0.857 23.16 
5 3 1. 0 00 27.03 
females 0 57 0.053 1 
1 26 0.192 3.62 
2 14 0.357 6.74 
3 7 0.571 10.77 
4 2 0.500 9.43 
5 3 1. 000 18.87 
quintile of the distribution. had a 10 times larger probability to have a high 
cholesterol level at the final examination than those who never had a high total 
cholesterol level (table 4.3 and 4.4). 
ln summary. there seems to be a moderately high degree of 'tracking' for 
total and HDL cholesterol in young people. Overall, males seem to have some-
what larger coefficients. both in the total as in the extremes of the distribution. 
However. to detect people who are at risk in the future it may be fruitful to 
look at change. rather than level over time. 
4.3 Patterns and determinants of change 
II has been suggested that a person may be better characterized by his rate 
of change than by the actual level of the determinanti.o.s In chapter 5 a hy-
pothetical model will be proposed which relates change. rather than level of a 
determinant. to risk of disease. Here. three approaches to the study of change 
will be presented. 
4.3.1 Horse-racing 
The concept of 'horse-racing· stems from Fletcher et al.6 in their study of 
pulmonary function. The model postulates that those with the highest initial 
level of a characteristic will experience the highest rate of increase in that 
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characteristic over time. To assess horse-racing for a characteristic it should 
be investigated whether there is a positive relation between change in serum 
lipids and initial lipid levels. The change in serum lipid levels in an individual 
can be obtained by linear regression of serum lipid levels on time, using the 
least-square approach. This method provides a slope, reflecting the change. and 
an intercept, which may serve as the estimated initial leveL The relation between 
change and initial level may then be assessed by regressing the individual slopes 
on the individual intercepts. The regression coefficients yielded by this model, 
are affected by regression toward the mean. i.e. they are either less positive 
or more negative than the 'true· coefficient. To adjust for this phenomenon. 
the method of Blomqvist7 can be adapted, which employs a i- coefficient. This 
A coefficient is the ratio of the average error of the individual slopes and the 
error of the initial values. The smaller A is, the smaller the adjustment for re-
gression to the mean. In our data (appendix 5) there was no evidence for 'horse-
racing', neither for total nor for HDL cholesterol. This fmding does not neces-
sarily imply that the study of change of lipid levels is irrelevant, it rather sug-
gests that there is no relation between change and initial level of serum chole-
steroL 
4.3.2 Level, trend and variability 
An excellent example of the study of change has been provided by Lauer et 
al. 8 For the longitudinal analysis of blood pressure data in children, they defined 
level. trend and variablity, as characteristics of interest. They also transformed 
all measured variables into age- and sex-specific percentile ranks for each survey 
year. For each subject the average of the percentile ranks of the measured var-
iables was calculated .and referred to as level. with percentile as unit. For each 
subject and each variable, a line describing the change of the study variable 
(in percentiles) over time was calculated by the method of least-squares. The 
slope of this line was referred to as trend, with percentiles per year as unit. 
The variation around this regression line is defined as the average squared de-
viation of the observed values from the predicted values. The square root of 
this quantity represents a measure of closeness of fit and was referred to as 
variability, with percentiles as unit. By defining ranges of leveL trend and va-
riability, special groups can be selected. For example, those with a high level, 
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a rising trend, and little variability, as those who are tracking toward future 
high values. or those with a low level. a flat trend and little variability. as 
those who consistently have a low level. Characteristics of these selected groups 
can be compared. in order to find determinants of change. 
4.3.3 Determinants of change 
Although the detemtinants of level of serum lipids have been extensively 
studied, much less attention has been paid to determinants of change. In prin-
ciple, the same kind of determinants can be investigated. measured either at 
the stan of the follow-up period or as a change over the time period under 
study. The use of a determinant measured at the stan of the study to charac-
terize the individual, may lead to an underestimation of the true relation of 
the determinant and the change of the study variable. For example. smoking is 
positively related to serum total cholesterol. and it may be related to the change 
in cholesteroL However. those who smoke at first measurement may stop. and 
those who do not smoke may take on this habit during follow-up. If smoking 
has an effect on change in cholesterol. this effect may be diminished by mis-
classification of the study subjectS. Relating change in a determinant (if possible) 
to change in the study variable may therefore be favoured. 
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Chapter 5 
ATHEROSCLEROSIS, A VIEW ON PREVENTION 
AND PREDICTION 
5.1 General 
Central issues in the epidemiological approach to atherosclerosis are its pre-
diction and prevention. Before discussing these aspects. a short expose of the 
function and metabolism of lipoproteins will be given. with special reference to 
their role in atherogeesis. More comprehensive reviews on lipid metabolism and 
atherosclerosis can be found in references I. 2. 12. 17 and 19. 
5.2 Lipid metabolism 
The major lipids of plasma or serum are unesterified cholesterol. cholesteryl 
esters. triglycerides. phospholipids and free fatty acids. Although in the present 
context much emphasis is given to the role of plasma lipoproteins in athero-
sclerosis. their physiological function is laid in transport of lipids between or-
gans in the body. Triglycerides. for example. synthesized in gut and liver. serve 
as energy supply for muscles. and cholesterol not only is an essential component 
of all cell membranes. but also is a precursor of steroid hormones produced by 
the adrenal gland and the ovary. Under normal conditions. there is a balance 
between cholesterol input and excretion. The input consists of exogenous chole-
sterol (about 335 mg/day) from the diet and from de novo synthesis in the liver 
(about 800 mg/day). Cholesterol "leaves the body primarily by way of the bile 
(600 mg/day). bile acids (400 mg/day). and the skin (85 mg/day). or is trans-
formed to steroid hormones (50 mg/day) and excreted by the urine. 
Lipids are water-insoluble substances and apart from free fatty acids. which 
are bound to albumin. they are transported through the plasma in spheri~al lipid-
protein multimolecular complexes. called lipoproteins. The surface of these lipo-
proteins is composed of amphipathic constituents and contains specific proteins 
(apolipoproteins). free cholesterol and phospholipids. Inside the core the hydro-
phobic triglycerides and cholesteryl esters are located. Tnere are several differ-
ent lipoproteins. categorized either by their density. as determined by ultracen-
trifugation. or by their electrophoretic mobility (table 5.1). 
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TABLE 5.1 
Categories of lipoproteins by density and electroforetic migration 
chylomicrons 
VLDL 
IDL 
LDL 
HDL 
density in g/ml 
< 0. 95 
< 1.006 
1.006- 1.019 
1.019 - 1.063 
1.063 - 1.21 
electroforetic migration 
pre-.B 
B 
VLDL-very low density lipoprotein, !DL•intermediate density lipoprotein, 
LDL•low density lipoprotein, HDL•high density lipoprotein. 
Most authors prefer the classification according to density. which reflects 
the different ratios of lipids and proteins. However. in view of the functional 
interrelationships of these lipoproteins. one may consider other classifications. 
The function and metabolism of the different lipoproteins will first be given. 
followed by a description of the apolipoproteins. 
5.2.1 Lipoproteins 
Chylomicrons are formed exclusively in the duodenum and jejunum and consist 
mainly of triglycerides. taken up from the diet. After secretion by the entero-
cytes into the intestinal lymph they enter the general circulation through the 
thoracic duct. The principal apolipoproteins of chylomicrons are apo A (subclasses 
I. II. and IV) and apo B (more specifically B-48). Apo C"s and E are incorporated 
in the chylomicrons after entry into the plasma compartiment by transfer from 
other plasma lipoproteins (mainly HDL). Apo C-!l is an obligatory cofactor of 
lipoprotein lipase. the enzyme involved in the lipolysis of triglycerides. The 
half-life of chylomicrons is only a few minutes as their degradation to core 
and surface remnants is a very fast process. Core remnants are taken up by 
the liver through apolipoprotein E receptors. whereas surface remnants are. at 
least partially. transferred to the high density lipoprotein (HDL3). 
Very low density lipoproteins (VLDL) are synthesized in the liver to trans-
port endogenous triglycerides in the blood. As a result of interaction with lipo-
protein lipase they are degraded to intermediate density lipoproteins (IDL). A 
major fraction of IDL is converted in the plasma compartment into low density 
lipoprotein (LDL). in a not fully understood process. while the rest is taken up 
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by the liver via the apo B.E receptor. The major apolipoproteins of VLDL are 
apo B (B-100). apo c·s and apo E. During the first step in VLDL catabolism 
(VLDL--;.. JDL) apo C"s are lost (transferred to HDL) while in the second step 
(IDL--7- LDL) apo E is lost and also transferred to HDL. 
Low density lipoproteins (LDL) carry about 65-70% of the total cholesterol 
concentration of the blood and about 90-95% of the total amount of apo B. They 
transport cholesterol (derived from the liver and secreted in VLDL) and chole-
sterylesters (taken up from HDL by cholesterylester transfer) to the peripheral 
somatic cells for membrane synthesis. Their catabolism has been elucidated by 
the work of Goldstein and Brown. 3 They demonstrated the existence of LDL 
receptors in fibroblasts. smooth muscle cells and lymphocytes by which the m-
tracellular cholesterol metabolism is regulated. The total number of receptors 
on a cell membrane is a reflection of the demand of the cell for cholesterol. 
The apo B component of LDL interacts with the receptor. enabling a receptor-
mediated endocytosis. After internalization of LDL into the cell three mecha-
nisms are activated: I) the de novo synthesis of cholesterol in the cell is de-
creased. 2) the transformation of cholesterol to its ester form is stimulated. 
and 3) the synthesis of cholesterol receptors is inhibited. In this way an accu-
mulation of cholesterol in the cell is avoided. When there is a defect in the 
LDL receptor (as is the case in familial hypercholesterolemia. see below) the 
serum cholesterol concentration increases dramatically as both LDL and its pre-
cursor IDL cannot be taken up in the cell. leading to an accumulation of (main-
ly) LDL in plasma. 
The metabolism of high density lipoproteins (HDL) has not yet been clari-
fied completely. Based on the density gradient analysis of plasma there are three 
subclasses (HDL1• HDL2 • HDL). The function of HDL is to transport cholesterol 
from the peripheral tissues back to the liver. It is thought to be formed in the 
plasma compartment out of precursors. synthesized by liver and gut. and surface 
remnants from chylomicrons and VLDL by interaction with lecithin:ckolesterol 
acyltransferase (LCAT) and lipid transfer proteins. During hydrolysis of chylo-
microns and VLDL discoidal particles are formed which consist of a phospholipid 
bilayer. free cholesterol and apo A-1. Direct synthesis of these disc shaped par-
ticles by liver and gut has also been demonstrated. The discoidal form of HDL 
("nascent" HDL) is rapidly transformed into a more global one by the uptake 
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and esterification of cholesterol. The enzyme LCAT plays an important role in 
the esterification and is also involved in the transformation of HDL3 to HDL2 
and HDL1• Several details of HDL metabolism are still unclear. for instance the 
transfer of cholesterylesters of HDL to the liver. This may be by a specific 
receptor-mediated process or by transfer of cholesterylesters to other lipopro-
teins. Also. little is known about the origin of apo A-ll and the mechanisms 
responsible for the regulation of the HDL subfractions. 
5.2.2 Apolipoproteins 
The above identified lipoproteins contain a number of structurally and func-
tionally different apolipoproteins. Up till now apo A. B. C. D. E and some sub-
categories. according to molecular weight. chemical composition and function 
have been identified. Table 5.2 gives an overview of the major apolipoproteins, 
their functional properties and the lipoproteins on which they are found. 
TABLE 5.2 
Categories of apolipoproteins, their lipoproteins and functions 
Apolipoprotein 
A-I 
A-II 
A-III 1- D) 
A-IV 
B-100 
B-48 
C-I 
C-II 
C-III 
E 
Liooorotein 
chylomicron, HDL 
HDL 
HDL 
chylomicron 
VLDL, IDL, LDL 
chylomicron 
chylomicron, VLDL, 
chvlomicron, VLDL, 
chYlomicron, VLDL, 
chylomicron, VLDL 
HDL 
HDL 
HDL 
Function 
co-factor of enzyme LCAT 
phospholipid-binding 
properties 
largely unknown (LCAT?) 
unknown 
interaction with apo B,E 
receptor 
structural component 
chylomicrons 
unknown 
cofactor of lipoprotein lipase 
inhibitor of uptake of VLDL by 
apo B/E and apo E receptors 
interaction with apo E and 
apo B,E receptor 
Apo A-1 is an important structural component of HDL. like apo A-11. and 
also a cofactor of the enzyme LCAT. Both apo A-l and apo A-ll are capable of 
forming complexes with phospholipids. which can bind cellular cholesteroL Apo 
A-IlL which is often referred to as apo D. probably also plays a role in this 
enzymatic activity. The function of apo A-IV is unknown. but is has been found 
in chylomicrons. Two forms of apo B can be distinguished. namely. apo B-48 
56 
(apparent in chylomicrons) and apo B-!00 (in LDL. IDL and VLDL). Apo B-48 is 
an obligatory structural component of chylomicrons as is apo B-100 for VLDL. 
Apo B-100 accounts for the receptor interaction with apo!ipoprotein B.E receptor 
cells. Apo C-II is a cofactor of the enzyme lipoprotein lipase and is mainly pres-
ent in chylomicrons and VLDL. Apo C-111. which has three subclasses. is prob-
ably a modulator of the interaction of apo B containing lipoproteins with the 
apo B/E and apo E receptors. C-apolipoproteins are also able to form protein-
lipid complexes with phospholipids and they are mainly present in chylomicrons. 
VLDL and HDL subfractions. Apo E. fmally, has a function in chylomicrons and 
VLDL. in providing the receptor interaction with apo B.E receptor cells and 
with apo E receptors of hepatic cells. 
5.2.3 Familial hypercholesterolemia 
Abnormal lipid or lipoprotein concentrations can be the result of a variety 
of defects in the above described metabolism. Familial hypercholesterolemia.4 
probably one of the best known lipid disorders. is strongly related to athero-
sclerosis and can be recognized in childhood. or even prenatally. 5 It is an auto-
somal dominant inheritable disease. based on a gene defect leading to impaired 
LDL receptor function. Homozygotes are unable to make functionally active LDL 
receptors. which. as discussed above leads to an enormous increase in serum 
cholesterol concentrations (above 600 mg/100 ml) and premature development of 
severe atherosclerosis (even by the age of 6 years old). Heterozygotes have a 
50% decreased capacity to synthesize active LDL receptors as compared to normal 
individuals. leading to cholesterol concentrations of over 300 mg/ I 00 ml and an 
increased risk of premature heart disease. Apart from rhe receptor mediated 
pathway to remove LDL from the plasma. also a 'scavenger' pathway has been 
postulated. which is independent of apo B/E receptors. Cells involved in the 
scavenger pathway include macrophages and histiocytes of the reticuloendothelial 
system. which in normal individuals remove about 15% of the total plasma LDL 
pool. Recent studies have suggested that macrophages may play an important 
role in atherogenesis. They can absorp and degrade enormous amounts of lipo-
proteins and store the cholesterol portion and eventually transform to foam 
cells. Because subjects wirh familial hypercholesterolemia have such a large LDL 
pool. much more LDL is metabolized by this scavenger pathway. which may ac-
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count for the increased amount of atherosclerotic lesions. Familial hyperchole-
sterolemia is a clinically very impressive disease. with a frequency in the popu-
lation of about 1-211000. It has also given rise to an outstanding model for 
lipid metabolism and its relation to atherosclerosis. However, for the prevention 
of coronary heart disease it is of limited importance, as only a small proportion 
of all heart disease patients has this inherited lipoprotein disorder (3-6% among 
survivers of myocardial infarction is known to have familial hypercholesterol-
emia'). 
5.2.4 Concluding remarks 
The role of cholesterol in the pathogenesis of coronary heart disease seems 
to be quite well established, although the mechanism by which it plays its harm-
ful role still needs to be further elucidated. The fmcling that the atherosclerotic 
lesion contained lipids, especially cholesterol. together with the observation of 
a dose-response relationship of the serum cholesterol level and the risk of coro-
nary heart disease in both cross-sectional and longitudinal studies, gave rise to 
a growing interest in serum lipids and their metabolism. The combination of 
biochemical studies and findings from clinical and epidemiological investigations 
led to the hypothesis that cholesterol measured in VLDL and LDL reflects the 
atherogenic property, whereas cholesterol measured in HDL might reflect a anti-
atherogenic (or protective) property of serum lipids.' Most of the serum total 
cholesterol is present in the LDL fraction, which may be an explanation of the 
observed relationships between cardiovascular diseases and serum total choleste-
rol.7 Lately, more emphasis has been put on apolipoproteins as markers for 
cardiovascular diseases. Like cholesterol, apolipoproteins are divided over the 
several lipoproteins with apo B being present in VLDL and LDL (the atherogenic 
lipid components) and apo A predominantly in HDL (the 'protective· agent). Be-
cause apolipoproteins are not only structural, but also functional components of 
lipoproteins, they might serve as better indicators or predictors of atheroscler-
osis and its clinical manifestations. than cholesterol fractions. 8 
5.3 Atherosclerosis 
Atherosclerosis has been described on a macroscopic. microscopic and even 
cellular and molecular level. Regularly, with advances in methodology, new in-
58 
sights occurred and new hypotheses were developed with regard to its patho-
genesis. This paragraph will give a short overview of the description of the 
atherosclerotic lesion. its presence early in life and some theories concerning 
its deve1opment. Most of the studies reviewed are restricted to atherosclerotic 
lesions in the aorta and coronary arteries. 
5.3.1 Macroscopic lesions 
The earliest studies on the morphological structure of the atherosclerotic 
plaque were performed in autopsy material. Macroscopically. three stages of 
atherosclerotic lesions were distinguished.' They included fatty streaks. fibrous 
plaques and complicated lesions. Fatty streaks were described as intimal lesions 
that could be stained with Sudan IV (because of their lipid content) and that 
showed no other change in the vascular wall. Fibrous plaques were described 
as elevated intimal lesions. that could be partially or completely stained with 
Sudan IV. When the lesion showed hemorrhage. ulceration. thrombosis or necro-
sis. it was referred to as a complicated lesion. 
These macroscopically visible lesions have been investigated in different popu-
lations. varying by age. gender. race and geographical location. It was noted 
that aortic fatty streaks were already present in children. in many of them be-
low the age of three years and in all of them older than three years. 10 Coronary 
artery fatty streaks. on the contrary. were rare below the age of l 0 years. but 
they rapidly increased in frequency during the next decade to become present 
in nearly all individuals of 20 years and older. 11 
Much work on the ·natural history· of atherosclerotic lesions in the aorta 
and coronary arteries has been performed as part of the International Athero-
sclerosis Project (lAP). 12 which studied autopsies from persons aged 10 years 
and older. in several geographic and ethnic groups according to a standard pro-
tocol. Some striking differences between the "behaviour" of fatty streaks in on 
the one hand the aorta. and on the other hand the coronary aneries. were ob-
served. The percentage of intimal surface with fatty streaks in the aorta showed 
an increase with age in most populations until about the age of 30 years. after 
which it leveled off or. more frequently. showed a decline. 13 This decline in 
percent intimal involvement might be a real one. suggesting the reversibility of 
fatty streaks. It might also be due to replacement of fatty streaks by fibrous 
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plaques (see below). or it might be due to the method of measuring fatty streaks 
as a percentage of the surface involved. as the aorta may have grown dispro-
portionally rapidly. The percentage of the coronary artery intimal surface with 
fatty streaks was shown to increase evenly from age I 0 until age 40 years. with-
out a tendency to regress in any population studied. 13 The presence and extent 
of aortic fatty streaks did not differ greatly between the various race-location 
groups. This observation is in contrast with that of fatty strea..'l(s in the coronary 
arteries. which showed more variation among the different groups. And coronary 
artery fatty streaks in those 15-39 years of age were to some degree related 
to more advanced lesions in older persons of the same populations. whereas 
aortic fatty streaks did not show such a relation. 12 This suggested. at least 
for corona:-y lesions. that fa!!y streaks might be precursors of more advanced 
atherosclerotic 1esions. 14 Although this traTlsformation can never be proven from 
autopsy studies. it has also been suggested by several other observations. For 
example. the age sequence: in all studies fatty streaks appeared at earlier ages 
than fibrous plaques. Also. in one study15 it was observed that the anatomical 
distribution of fatty streaks within the coronary arteries was similar to the 
distribution of fibrous plaques in coronary arteries of older persons of the same 
population. And. in another study16 it was demonstrated that histologic charac-
teristics of fatty streaks di.ffered among populations with different dispositions 
to severe atherosclerosis. suggesting a gradual transition of fatty streaks into 
fibrous plaques. 
5.3.2 Microscopic lesions 
With advancing techniques more detailed aspects of early and advanced athe-
rosclerotic lesions could be investigated. Also. the morphology of the normal 
vascular waH and its changing pattern with age became matters of interest. 
The roles of vascular endothelium. smooth muscle cells. macrophages and mono-
cytes in the pathogenesis of atherosclerosis were and still are studied. discussed. 
revised and updated. 17·18•19 
The normal artery wall consists of three morphologically distinct layers. The 
intima. with a monolayer of endothelial cells adjacent to the arterial lumen, 
resting on a layer of elastic fibers. the internal elastic Jamina. Between the 
endothelial cells and the elastic fibers a variable amount of extracellular connec-
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tive-tissue matrix and isolated smooth-musde cells are present. With increasing 
age multiplications of the internal elastic lamina and proliferations of the inci-
dental smooth muscle ce!J occur in the coronary arteries. resulting in a so-called 
musculo-elastic layer. 20 This musculo-elastic layer is less pronounced in ethnic 
groups known to have a lower incidence of coronary heart disease21 and its 
composition changes with age. In younger persons smooth-muscle cells and elastic 
fibers predominate, whereas in o]der persons this layer is mainly composed of 
coHagen fibers. The media. or middle layer, consists of diagonally oriented 
smooth-muscle cells. surrounded by variable amounts of collagen. small elastic 
fibers and proteoglycans. The morphology of the media does not generally change 
with age. The adventitia. or outermost layer of the artery. consists principaHy 
of fibroblasts. some smooth-muscle cells and bundles of collagen. surrounded by 
proteoglycans. 
The microscopical description of the above mentioned 'dassica1 atheroscle-
rotic lesions·. especially the fatty streak and fibrous plaque. includes di.iferent 
cellular components. some of which are not visible at gross inspection. Stary 
investigated systematically. in several hundreds of children and young adults. a 
highly vulnerable site of the coronary artery system. the proximal portion of 
the left anterior descending artery."' He noted that in those less than 10 years 
of age. no fatty streaks were grossly visible. but that microscopically isolated 
monocytes and macrophage foam cells frequently were present in a thickened 
intima. In those older than 10 years. clusters of monocytes and macrophages 
were observed. together with lipid containing smooth muscle ceHs. whereas with 
the unarmed eye no fibrous plaques were visible. By the age of 15 years. foci 
of necrosis began to appear in the intima and after age 20. areas with necrotic 
foci associated with lipid loaden smoothmuscle cells and macrophage foam cells 
became larger and more frequent. Macroscopically. some of these lesions resem-
bled uncomplicated fatty streaks. while others had the gross characteristics of 
fibrous plaques. However. the age sequence of the occurrence of microscopical1y 
visible changes in the intima of a coronary artery strongly supports the view 
that coronary atherosclerosis begins in childhood. lt suggests that the process 
may begin with monocyte and macrophage infiltration. and that smooth muscle 
cell lipid accumulation and intimal necrosis are later developments. Although 
early atherosclerotic lesions in the aorta appear to be identical to those in the 
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coronary artery. it is more difficult to trace the evolution of fatty streaks to 
fibrous plaques. In the aorta there is no limited anatomic predilection site for 
atherosclerosis and furthermore the distribution of aortic fibrous plaques in a-
dults according to sex. race and anatontical position. does not correlate with the 
distribution of aortic fatty streaks in younger persons. In summary. there is 
evidence that coronary atherosclerotic lesions begin in childhood and develop 
into adult life. Aortic atherosclerotic lesions presumably begin early in life as 
well. but it can not be concluded definitely that the early aortic lesions progress 
into more advanced atherosclerosis. 
5.3.3 Hypotheses 
The pathogenesis of atherosclerosis has been subject to many hypotheses 
arising from microscopical observations of atherosclerotic plaques. animal models 
or culture of cells implicated in atherosclerosis. In this paragraph an outline of 
the major theories will be presented. For more details. references 17. 19 and 
20 are useful. 
The lipid rheory· assumes an increased transport of plasma lipoproteins 
through the endothelium. as a consequence of high plasma LDL concentrations. 
The elevated lipid levels in the vessel wall give rise to an increased uptake by 
smooth muscle. endothelial or macrophage cells. When the capacity of the cells 
to take up lipids is exceeded. cholesterol and other lipids accumulate. 
In the response·to-injury hypothesis the damage of the endothelial barrier 
is supposed to be the initiating event. 17 Factors such as hyperlipidemia. high 
blood pressure. hormone dysfunction or others may injure the endothelium. The 
underlying subendothelial connective tissue becomes exposed to platelets and 
other elements in the circulation. Microthrombi occur and platelets release the 
contents of their granules. Arterial smooth-muscle cells migrate from the media 
into the intima. proliferate and produce large amounts of connective tissue ma-
trix. Lipids are deposited both within the cells and in the surrounding connective 
tissue matrix. Ultimately. restoration of the endothelial barrier occurs and the 
lesion regresses if the source of endothelial injury has disappeared. If however. 
the injury is continuous or repeated. further proliferation of smooth-muscle 
cells and accumulation of connective tissue and lipids occur. The balance between 
re-endothelialization and cell proliferation and necrosis may be disturbed. result-
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ing in an atherosclerotic lesion. Risk factors such as hyperlipidemia. hypertension 
and smoking may influence this balance by interfering with the normal response-
to-injury of tissue. 
The monoclonal hypothesis proposes that each lesion of atherosclerosis is 
derived from a single smooth-muscle cell that serves as a progenitor for the 
remaining proliferative cells. 23 The atherosclerotic lesion may be seen as a ben-
ign neoplasm arising from one transformed cell. that may be regulated by other 
factors than the normal arterial smooth-muscle ce11. 
The clonal-senescence hypothesis is based on the age-related decline in repli-
cative activity of cells in culture. 24 A paradoxical function of declining stem 
cell activity in the arterial media is suggested to be the underlying mechanism 
of atherosclerosis. The intima and media contain a relatively small amount of 
stem cells. which replicate to form smooth muscle cells. which then secrete 
'chalones·. that inhibit further replication of stem cells. With increasing age 
the concentration of chalones in the intima is decreased. as a function of de-
creased replication of smooth-muscle cells in the media and a diminished diffu-
sion of chalones into the intima. resulting in smooth-muscle cen accumulation 
in atherosclerotic plaques. The endothelial stem cells may also play a role ac-
cording to this hypothesis. Diminished activity of these cells might affect the 
endothelial barrier. resulting in the sequelae described above. 
These proposed hypotheses are not necessarily mutually exclusive. It has been 
the merit of Steinberg"' to combine the lipid infiltration hypothesis with the 
endothelial injury hypothesis. Others have gone in more detail in investigating 
the roles of endothelial. smooth muscle. macrophage or monocyte cells. trying 
to find factors that regulate their actions and lead to formation of 
atherosclerotic plaques. Recently. the role of monocytes as initiators of the 
atherosclerotic lesion. has been suggested. 19 Faggiotto et al.26 observed in pig-
tail monkeys. who were fed a high-fat. high-cholesterol diet. clusters of mono-
cytes on the endothelium. often in junctional areas. where they migrated suben-
dothelially. accumulated lipids and took on the appearance of foam cells. These 
changes constituted the first stage of fatty streaks in these animals. similar to 
fatty streaks observed in humans. These fatty streaks enlarged by accumulation 
of smooth muscle cells migrating from the media into the intima and also ac-
cumulating lipid. It has been suggested that accumulation of monocytes on hyper-
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cholesteroiemic endothelium was due to changes in the monocyte as well as in 
endothelial cells or in the underlying smooth muscle cell. 27 After a few months 
of elevated LDL levels. the endothelium retracts over the fatty streak. princip-
ally at branches and bifurcations. leaving macrophages and connective tissue 
matrix exposed to the circulation. In this way platelets have the opportunity to 
adhere. aggregate and release their granule contents. Platelet derived growth 
factor (PDGF) may be of particular importance in atherosclerosis. because it is 
both chemotactic and mitogenic. It therefore can induce both smooth-muscle 
cell migration ar1d proliferation. 28 A PDGF-Jike factor is also produced by the 
endothelium. 29 by macrophages30 and by smooth-muscle cells themselves. 
5.3.4 Concluding remarks 
It is reasonable to assume that atherosclerosis has its origin in childhood 
and that the early atherosclerotic lesions develop into more complicated pla-
ques. at least in coronary aneries. Endothelial cells. monocytes. macrophages. 
smooth-muscle cells. and platelets presumably ali play a role in the atherogenic 
process. The intimal smooth-muscle cell proliferation may be the predominant 
feature. initiated by a response to injury mechanism. However. more has to be 
known about the factors that initiate and complicate the process. 
5.4 Prevention 
Preventive activities may be focussed on either the whole population. or on 
high risk groups. There has been much debate which strategy has to be pre-
ferred.31·32 and what effect either of the strategies has in terms of prevented 
number of cases of disease. To answer the question of the relative merits of 
these approaches. a hypothetical model for the aetiology of chronic diseases. in 
panicular cardiovascular diseases. may be considered. This hypothetical model 
has the following assumptions about the relation between the characteristic of 
interest (e.g .. serum cholesterol or blood pressure) and the disease (e.g .. coronary 
heart disease): 
(I) it proposes that the ·genetic" level of the study characteristic (e.g .• serum 
cholesterol) is not related to the probability of disease. 
(2) it suggests that the rate of increase of the characteristic over time deter-
mines the disease probability. 
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These two elements of the model are based on the thought that it is in gen-
eral on a priori grounds unlikely that the level of a biological characteristic at 
birth is a risk factor for a certain disease. For instance. in the case of athe-
rosclerosis. it may be reasonable to think that there is a state of equilibrium 
between the vascular endothelium and serum cholesterol or blood pressure. The 
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vascular endothelium may be resistant against the 'genetic background' level of 
these characteristics, whether or not they are high at birth. However, with a 
high rate of change of the characteristic, this equilibrium may be distorted. 
Hence, according to this reasoning, it is the rate of increase in the biological 
characteristic that determines the risk. and this may reflect 'genetic suscepti-
bility" for the disease. It should be emphasized that genetic predisposition cannot 
be perceived without its interaction with environmental factors. Therefore, a 
person may inherit the susceptibility to a rise in a biological characteristic and 
thereby his disease risk, but the realization of this susceptibility, i.e., the rise 
in the characteristic~ can only occur in a certain, 'riskful'. environment. 
Consider the following three situations. graphically presented in figure 5 .!, 
in which the left side shows the relation between the determinant and age (from 
T1 - > T2) and the right side the distribution of the determinant at a certain 
age (T2). and the relation between the disease risk and the level of the deter-
minant at age T
1 
and T2 • 
Situation A 
This situation is the basic one: all subjects have a constant genetic level of 
the characteristic over time. This model has the following elements: 
* At T2 the distribution of the determinant is the same as at T1• 
* The disease probability is invariant over the determinant. 
* There is a certain background risk~ because of other causes operating. 
Situation B 
In this situation all members of the population experience the same rate of in-
crease of the characteristic. This has the following implications: 
* At T2 the whole distribution of the determinant is shifted to the right. 
* The disease risk is similarly increased for each individual (dotted and 
solid horizontal line). 
* Although the risk is increased compared to situation A, the characteristic 
under study is not a risk factor, because its level within this population is 
unrelated to the disease. 
In the case of between-population comparisons the above described situations 
might occur. Population A, with an average low level of the characteristic also 
has a low level of risk, and population B, with an average higher level, has an 
increased risk. It should be noted, however. that the higher level of risk of 
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population B is based on the rate of increase of the characteristic. rather than 
on its leveL A way to explore whether this is the case, is to compare childhood 
levels. or the rate of increase between childhood and adult levels of the charac-
teristic, between populations. Because all members of the population in B are 
similarly susceptible to the disease, the best prevention strategy here would be 
the total population approach. This should aim at the prevention of increase of 
the characteristic and therefore intervene relatively early in life. 
Situation C 
This situation describes a different rate of increase of the characteristic for 
the members of the population. This has the following implications: 
* The distribution of the determinant becomes skewed at T2• 
* The level of the determinant is related to the disease risk. because the 
highest category of the determinant is loaded with susceptibles, i.e .. with 
subjects who had the largest increase. 
* The largest proportion of preventable cases is present at the highest 
levels of the determinant. 
This situation probably is the best reflection of true life. It might also provide 
pan of the explanation for the fact that not all people with high risk factor 
levels experience the disease. The high level may in some individuals reflect a 
high 'genetic background' level. rather than a high rate of increase of the char-
acteristic over life. The reverse holds for those with a relatively low level. In 
this situation the high-risk approach probably would be most effective for dis-
ease prevention, because especially later in life. the susceptibles are best indi-
cated by their high risk factor leveL 
What are the implications of this reasoning? For aeriologic research it sug-
gests that perhaps the increase over time rather than the level of blood pressure 
or cholesterol in relation to disease should be investigated. A.nd that perhaps 
one should focus more on patterns of increase and try to find early markers 
for the rate of increase. For prevention this means that the popuJation approach 
may be panicularly suited early in life. to prevent the rise of a determinant. 
whereas the high-risk approach may be suited better later in life, to include 
the susceptibles and prevent them from further increasing their risk factors. In 
this way. the whole-population and the high-risk strategy go hand in hand in 
the prevention of chronic diseases. However. if one desires to use the high-risk 
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approach also at young ages. it becomes necessal)' to find a marker for the 
susceptibles. i.e .. those who will show an increase in the characteristic over 
time. This will be discussed in the final section of this chapter. 
5.5 Prediction 
The study of the early prediction of atherosclerosis or coronary heart disease 
is important in two aspects: aetiology and prevention. If factors measured early 
in life. can be identified as predictors for hean disease at older ages. more 
insight into the early pathogenesis of atherosclerosis may be gained. and high-
risk persons may be detected in an early stage. The question of aetiology may 
preferably be investigated in a study which has atherosclerosis as an endpoint. 
whereas the question of prevention may also be investigated in a study with 
clinical disease as endpoint. The design of the study therefore is of importm1ce. 
This section starts with a discussion of possible study designs. before it will 
give the major findings from studies of the predictive value of serum lipids in 
childhood for coronary heart disease or atherosclerosis later in life. 
5.5 .I Study design 
The study designs that will be discussed here are based on one of the fol-
lowing characteristics: follow-up of children. assessment of clinical disease or 
atherosclerosis in parents. or assessment of atherosclerosis in children them-
selves. 
Follow-up of children 
The Framingham Heart Study33 serves as the paradigm for epidemiological 
inquiries into the prediction of cardiovascular diseases in adult persons. In this 
study a cohort comprising 5.127 subjects. aged 30 to 62 at entry. has been reg-
ularly examined ar1d followed for more than 30 years. If a cohort of children. 
in wich risk factors have been measured. has to be followed until the age that 
they may develop coronary heart disease. it would take even more years and 
more effort to avoid loss to follow-up. Therefore. although longterm observations 
would be preferable. for practical reasons studies of this type have not been 
conducted. However. a mid-way solution could be a retrospective follow-up study. 
Over the past decades many data on risk factors in children have been collected 
(chapter 3). In countries with an accurate civil registration. it may be possible 
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to trace those children over many years. and study their present health status. 
An advantage of this type of study probably is that the subjects would be less 
influenced in their behaviour by the study itself. StilL it would be a tremendous 
effort and other study designs may be favoured for being more efficient. 
Parents with clinical disease 
Familial aggregation of cardiovascular diseases has since long be recogniz-
ed. 34 ·35•36 Although the m~or risk factors for heart disease also seem to clus-
ter in families.3738·39 this familial aggregation appears to explain only a part 
of the farnilial aggregation of clinical disease. However. as children of parents 
with coronary heart disease are at far greater risk of developing atherosclerotic 
diseases than children of parents without heart disease.40 ·41 the disease status 
in parents can be used to discriminate two groups of children. The next step is 
to compare putative risk factors of these children. who are prone to atheroscle-
rosis based on their family history. with a group of children with a negative 
family history for heart disease. In the analysis. average levels of risk factor 
variables can be compared between the groups. but also a discriminant analysis 
can be performed to find the variable that best discriminates the two groups 
of children. 
In this design the decision which of the clinical manifestations of cardio-
vascular disease has to be chosen and the assessment of the presence or ab-
sence of this disease are paramount. Clinical manifestations of atherosclerosis. 
!ike angina pectoris. myocardial infarction. cerebral stroke. or sudden death 
can be studied as one group of cardiovascular diseases. or they can be consid-
ered separately. When there is a strong indication for a different pathogenesis 
it may be better to study the clinical diseases separately. Misclassification may 
occur by absence of clinical symptoms in parents who already have a consider-
able amount of atherosclerosis. although they may form a special group. The 
age of the parents under study is of major importance. especially because most 
of the concern goes to the premature occurrence of heart diseases. 
Finaily. the outcome of studies with this design needs some comment. When 
in children whose parents have cardiovascular diseases elevated levels of risk 
factors are found. this may just reflect familial aggregation of risk factors. On 
the other hand. when abnormal lipid levels are already observed in childhood. 
it may be concluded either that those lipids are involved in the early pathoge-
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nesis. or that they are just predictors or markers for altered metabolism. The 
presence of clinical disease in parents may also be used as a screening tool to 
fmd susceptibles. either those with elevated risk factor levels at young ages. 
or those who will experience a large increase (see section 5.4). 
Parents with atherosclerosis 
Following a saying of Dr. Lewis Kuller42 that in epidemiological research 
"sooner or later we must study coronary atherosclerosis rather than heart at-
tacks'. it may have additional merit to study the offspring of subjects who un-
derwent coronary angiography. Although this method restricts the prediction of 
cardiovascular diseases to coronary heart disease. it may provide insight into 
the early determinants of the atherosclerotic process. The utility of coronary 
arteriography in the study of the natural history of coronary heart disease has 
been carefully reviewed by Pearson.43 The major advantages of using coronary 
angiography over clinical criteria is the improved accuracy of definition of case 
and control groups. Besides. coronary angiography makes it possible to subdivide 
cases into categories with varying severity of disease. However. in studies based 
on coronary angiograms. selection bias may occur for several reasons. Only sur-
vivors of myocardial infarction can be selected for angiography and this may 
lead to an underrepresentation of severe atherosclerosis. Also, those who do 
not have clinical symptoms, like angina pectoris, may not have a coronary angio-
graphy and this may lead to an underrepresentation of those with minor athero-
sclerotic lesions. However. for the study of early predictors of atherosclerosis 
this is of less importance than the diagnostic suspicion bias.44 which may oper-
ate if those with high risk factor levels are more likely to be subject to coro-
nary angiography. Selection bias may also be related to the recruitment of the 
control series who may be patients with clinical symptoms but without evidence 
for atherosclerotic lesions. They conceivably may be patients who are very con-
cerned about their health status, which may be reflected in lower than average 
levels of the risk facwrs. The design of studies of predictors of atherosclerosis 
can be the same as described for the study based on clinical disease in the par-
ents. 
Atherosclerosis in childhood 
Although coronary angiography serves as the 'gold standard' in assessing 
the amount of atherosclerotic lesions, it does not allow to be applied randomly 
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to the population. This method may bring about some complications. involves 
exposure to radiation. is quite expensive and not comfortable for the patients 
undergoing it. In the near future non-invasive techniques may be developed that 
are as reliable as coronary angiography in assessing atherosclerosis.• but that 
are without its disadvantages. Such a technique may then be used to measure 
early atherosclerotic lesions. like fatty streaks. Until now. there has been only 
one post-mortem study,'' that has related early atherosclerotic lesions to risk 
factor levels in children and young adults. New non-invasive methods may not 
only relate the extent of fatty streaks to risk factor levels cross-sectionally, 
but they may also enable relating early atherosclerotic lesions to more advanced 
fibrous plaques longitudinally. In this way the natural history of atherosclerosis 
may be followed during life. 
5.5.2 Study results 
A number of investigators have studied the relation between parental car-
diovascular disease and serum lipids in their children.46-" In general, elevated 
serum total cholesterol or triglyceride levels.46-'0-''·" or decreased HDL cho-
lesterol levels" were observed in children of parents with cardiovascular disease, 
notably myocardial infarction. Most of the studies aimed at finding high-risk 
subjects. rather than at finding markers or predictors of future disease. Lately. 
apolipoproteins have been suggested to be better predictors or markers of coro-
nary heart disease. s6-60 Sniderman et al. 55 observed elevated levels of apo B 
in children of parents with myocardial infarction and hyperbetalipoproteinemia 
(elevated levels of apo B. in the presence of normal LDL cholesterol concen-
trations). They concluded that elevated levels of apo B in families with prema-
ture coronary heart disease occurred long before clinical symptoms emerged. 
and that therefore this metabolic disorder may be of importance in the pathoge-
nesis of atherosclerosis. In our study (appendix 6) we also found higher levels 
of apo B in sons of fathers with coronary atherosclerosis. as determined by 
angiography. compared to sons of fathers without coronary atherosclerotic ob-
structions. Our findings still may reflect familial aggregation of apo B levels, 
although we did not select our patients on their (apo)lipoprotein levels. More-
over. a discriminant analysis in the fathers showed the ratio of HDL-choleste-
rol!LDL cholesterol to be the best discriminator. whereas in the sons the ratio 
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of apo B/apo A-! best discriminated between sons of fathers with and sons of 
fathers without coronary atherosclerosis. Whether apo B is implicated in the 
early pathogenesis of atheroscleroris. or just a marker for those susceptible 
for future disease. cannot be concluded from our study. 
5.5.3 Concluding remarks 
Tne relation of serum lipids and atherosclerosis early in life deserves further 
investigation. but fruitful epidemiological studies await the further development 
of non-invasive techniques to detect early atherosclerotic lesions. The level and 
determinants of cholesterol subfractions. apolipoproteins. the role of macropha-
ges. and endothelial and smooth muscle cells need further inquiry. with emphasis 
on studies early in life. If possible. in aetiologic research the study of risk fac-
tors should be related to the underlying process. the atherosclerotic lesion. 
rather than to clinical manifestations of this process. For both aetiology and 
prevention the search for early markers or predictors of future cardiovascular 
diseases should be continued. 
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Chapter 6 
SUMMARY 
The relationship between serum lipids and the occurrence of atherosclerosis 
and its clinical sequa1ae has been extensively investigated_ in adults. However. 
as evidence is increasing that atherosclerosis already starts in childhood. it 
may have merit to study its determinants early in life. The study of serum 
lipids in the young as described in this thesis comprises the following 
questions: what are the average levels and determinants of serum lipids? Is 
there a relation between lipid levels measured early in life and later on? And 
what are the possibilities early in life of prevention and prediction of future 
heart diseases? (chapter 1). 
To answer these questions different types of study design and data-analytic 
method were used. Most of the data collected in this thesis. especially those 
on total and HDL cholesterol. are derived from a longitudinal investigation in 
5-19 years old youngsters living in the Dutch town of Zoetermeer. Apart from 
this study population. two studies were carried out in young subjects selected 
from hospital populations (chapter 2). 
The question related to the level and distribution of serum lipids at young 
ages has been investigated in different populations. Although considerable dif-
ferences in levels of total cho~esterol betv.reen these populations have been re-
poned. in most studies a 'd~p' in serum cholesterol concentrations between 
ages 10 and 16 years was observed. For HDL cholesterol levels a remarkable 
difference between males and females in their early twenties was observed in 
many studies. The findings in our study closely resembled these observations. 
Apart from age and gender. the following determinants were studied in their 
relation to serum lipid levels in children and young adults: familial history. 
body height and weight. hormonal factors (oral contraceptives. pregnancy) and 
life habits. like smoking. use of alcoholic beverages and physical activity. Age. 
parental cholesterol levels and body weight were the most important 
determinants of total cholesterol levels in youngsters. In accordance with other 
studies. a positive association between body weight and total cholesterol was 
observed in our study. however. only in those older than 15 years of age. This 
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finding suggests that early in life other variables (e.g.. factors related to 
growth and maturation) may play a part in determining serum lipid levels. The 
most important determinants of HDL cholesterol were gender. age and body 
weight (the latter only in males older than 15 years). The relation between 
exogenous sex hormones and serum lipids was studied in two longitudinal 
investigations. Young women who started using oral contraceptives showed a 
larger increase in serum total cholesterol. than women who did not use oral 
contraceptives. Extremely tall prepubenal girls. who were treated with 
ethinylestradiol to inhibit further growth. showed a considerably larger 
increase in serum total cholesterol than an age matched reference group. 
Hormonal factors may also be involved in the increase in serum total and HDL 
cholesterol levels during pregnancy. When serum lipid levels of pregnant women 
were compared to the levels one year before and one year after pregnancy. it 
was observed that the year after pregnancy serum total cholesterol levels 
returned to pre-pregnancy levels. whereas HDL cholesterol levels dropped 
below pre-pregnancy concentrations (chapter 3). 
The study of the natural history of serum lipids in the young raises two 
questions. First. there is a question of prediction: is there an association be-
tween cholesterol levels early in life and later on? This is often referred to as 
"tracking·. Second. there is a question concerning the etiology of hypercholes-
terolemia: what are the patterns and determinants of change in serum lipid 
concentrations? There are several methods to assess the magnitude of tracking. 
In general. higher tracking coefficients were observed in males than in 
females. for both total and HDL cholesterol. The coefficients for total 
cholesterol were higher than for HDL cholesterol. With regard to patterns and 
determinants of change. a negative association was observed between initial 
level and subsequent change of total and HDL cholesterol. even after 
adjustment for regression to the mean. The change ir, total choles:erol was 
positively associated with cholesterol level in the mother (in males). initial 
weight (in males). initial smoking habit (in males). and negatively associated 
with initial use of oral contraceptives (in females). The change in HDL 
cholesterol was positively associated with initial weight (in females) and 
negatively associated with change in weight (chapter 4). 
In the final chapter some background information is given on lipid 
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metabolism and atherosclerosis. Also. a hypothetical model on the aetiology of 
chronic diseases is presented and the implications for aetiological research and 
prevention are discussed. If the increase over time rather than the level of a 
determinant is of importance in relation to diseases. for preventive actions the 
population approach may be particularly suited early in life and the high-risk 
approach later in life. In the last part of this chapter some aspects of early 
prediction of atherosclerosis or cardiovascular diseases are discussed (chapter 
5). 
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Chapter 7 
SAMENVATIING 
De relatie tussen serum lipiden en het optreden van hart- en vaatziekten of 
atherosclerose is met name bij volwassenen uitvoerig bestudeerd. Daar echter 
de opvatting dat atherosclerose op jonge leeftijd begint. steeds meer terrein 
wint. lijkt het zinvol de risikofaktoren reeds bij jeudigen te bestuderen. De 
vraagstellingen met betrekking tot serum lipiden bij jongeren die in dit proef-
schrift aan de orde komen zijn: wat zijn de gemiddelde waarden en deterrni-
nanten van serum lipiden? Is er een verband tussen serum ]ipiden op jonge 
leeftijd en later in het Ieven? En wat zijn de mogelijk.heden vroeg in het leven 
ten aanzien van preventie en prediktie van hart- en vaatziekten? (hoofdstuk 
1). 
De verschillende vraagstellingen met betrekking tot het onderzoek van 
serum lipiden bij jongeren leidden tot verschillende typen onderzoek en 
analytische modellen. Het merendeei van de gegevens over serum Iipiden. met 
name totaal en HDL cholesterol. is afkomstig uit een longitudinaal onderzoek 
onder Zoetermeerse jongeren. die aanvankelijk 5-19 jaar oud waren. Daarnaast 
werden twee onderzoekingen verricht bij jongeren afkomstig uit een ziekenhuis 
populatie (hoofdstuk 2). 
De vraag met betrekking tot de hoogte van het cholesterol op de jonge 
leeftijd. is in verschillende populaties onderzocht. Hoewel er aanzienlijke 
verschillen bestaan in de cholesterol spiegel tussen deze populaties. Iaten de 
meeste onderzoekingen bij jongeren een ·dip· zien in de totaal cholesterol 
koncentratie tussen de leeftijd van 10 en 16 jaar. Voor het nivo van HDL 
cholesterol tonen de meeste onderzoekingen een opmerkelijk verschil tussen 
mannen en vrouwen rond het twintigste levensjaar. Deze resultaten werden ook 
in onze studie gevonden. Naast leeftijd en geslacht werden de volgende 
faktoren onderzocht als mogelijke deterrninanten van het nivo van de serum 
Iipiden bij kinderen en jong volwassenen: familiaire achtergrond. gewicht. 
horrnonale faktoren (orale antikonceptiva. zwangerschap) en Ieefgewoonten. 
zoals roken. alcohol gebruik en lichamelijke inspanning. Leeftijd. het 
cholesterol nivo van de ouders en het gewicht waren de belangrijkste 
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determinanten van totaal cholesterol bij jongeren. In overeenstemming met 
diverse andere onderzoekingen vonden wij een positief verband tussen gewicht 
en totaal cholesterol, echter alleen in personen. ouder dan 15 jaar. Deze 
bevinding suggereert dat vroeg in het Ieven mogelijk andere faktoren van 
invloed zijn op het nivo van de serum lipiden, dan later in het Ieven. Faktoren 
als groei en rijping zouden op jongere leeftijd van belang kunnen zijn. De 
belangrijkste determinanten van HDL cholesterol waren: geslacht, leefrijd en 
gewicht (dit laatste aileen voor mannen ouder dan 15 jaar). De invloed van ex-
ogene hormonen op serum lipiden bleek met name uit twee longitudinale 
studies. Jonge vrouwen die de pi! gingen gebruiken vertoonden een sterkere 
stijging in totaal cholesterol, dan vrouwen die niet de pil gebruikten. Extreem 
lange prepuberale meisjes, die werden behandeld met oestrogenen om verdere 
groei tegen te gaan, vertoonden een aanzienlijk grotere stijging in totaal 
cholesterol dan een voor leeftijd gematchte kontrole groep. Hormonale faktoren 
zijn mogelijk ook betrokken bij de stijging in totaal en HDL cholesterol 
gedurende de zwangerschap. Het jaar na de zwangerschap bleek totaal 
cholesterol weer op bet nivo van voor de zwangerschap te zijn teruggekomen. 
Voor HDL cholesterol echter, vonden wij een daling in het nivo in het jaar na 
de zwangerschap ten opzichte van het jaar voorafgaand aan de ZWlU)gerschap 
(hoofdstuk 3). 
Bij de bestudering van het natuurlijk beloop van serum lipiden op jonge 
leeftijd zijn twee vragen te onderscheiden. Ten eerste. de vraag van prediktie: 
is er een verband tussen cholesterol koncentraties op jonge leeftijd en later in 
het Ieven? Vaak wordt dit verband aangeduid met de term 'tracking'. Ten 
tweede, de vraag met betrekking tot de etiologie van hypercholesterolemie: wat 
zijn de patronen en determinanten van verandering in serum lipiden 
koncentraties? Er zijn verschillende methoden om de mate van tracking vast te 
stellen. Over het algemeen werden hogere tracking coefficienten voor jongens 
dan voor meisjes gevonden, zowel voor totaal als HDL cholesteroL De 
coefficienten voor totaal cholesterol bleken boger dan voor HDL cholesterol. 
Wat betreft patronen en determinanten van verandering, werd er een negatief 
verband gevonden tussen initieel nivo en de mate van verandering in totaal en 
HDL cholesterol. zelfs na korrektie voor regressie naar het gemiddelde. De 
verandering van totaal cholesterol was positief geassocieerd met cholesterol 
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nivo van de moeder (bij jongens), initieel gewicht (bij jongens), initiele 
rookgewoonten (bij jongens), en negatief geassocieerd met initieel pilgebruik 
(bij meisjes). De verandering in HDL cholesterol was positief geassocieerd met 
initieel gewicht (bij meisjes) en negatief geassocieerd met verandering in 
gewicht (hoofdstuk 4). 
In het laatste hoofdsruk wordt achtergrond informatie gegeven over lipiden 
metabolisme en atherosclerose. Vervolgens wordt een hypothetisch model aan-
gaande de etio!ogie van chronische ziekten gepresenteerd met de implikaties 
voor etiologisch gericht onderzoek en preventie. Indien de verandering en niet 
het nivo van een detenninant van belang is in relatie tot ziekten, dan verdient 
het voorkeur preventieve akties op jonge leeftijd op de hele bevolking te rich-
ten, terwij! op oudere leeftijd de benadering van groepen met een hoog risiko 
meer geschikt is. Tenslotte worden enige aspecten van vroege prediktie van 
atherosclerose of hart- en vaatziekten besproken (hoofdstuk 5). 
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Summary 
Serum total cholesterol and its putative determinants were measured in 5.089 
subjects. ages 5-30 years. comprising 76% of the total population of two districts 
of the Dutch town of Zoetermeer. From this group 596 subjects. ages 5-19 years. 
were randomly selected. and distributions and determinants of high-density lipo-
proteins (HDL) cholesterol were studied in 458 of them. The variables studied 
included body weight; Quetelet index; menarche; parental cholesterol; physical 
activity; consumption of coffee; alcohol and tobacco; and use of oral contracep-
tives. 
Mean total cholesterol levels showed a decrease in both boys and girls be-
tween the ages of I 0 and 16 years. Mean HDL cholesterol levels remained the 
same until the age of 17. after which they showed an increase for females and 
a decrease for males. Total cholesterol was associated with age. body weight 
(in those older than 15 years). and parental cholesterol concentrations. For HDL 
cholesterol the most important determinants were gender. age and body weight 
(the latter only for males 15 years and older). These findings suggest that during 
growth and maturation the determinants of serum cholesterol are different from 
those later on in Hfe. 
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INTRODUCTION 
Many studies have shown that the serum cholesterol levels in adults predict 
the occurrence of cardiovascular diseases (CVD).8.17•26 There is a consensus 
that serum total cholesterol and its fractions play a part in athero- and throm-
bogenesis. 20 ·28 Evidence is increasing that the roots of atherosclerosis may be 
traced to early life. 3 Therefore. investigations of the distribution, determinants 
and development of serum cholesterol in childhood may provide insight into the 
etiology as well as the prevention of CVD. 
This report deals with the distribution and determinants of serum total chole-
sterol and high density lipoprotein (HDL) cholesterol in 5,089 subjects ages 5-30 
years, of a general Dutch population. 
SUBJECTS AND METHODS 
Population 
Between April 1975 and June 1978 all residents ages 5 years and over of 
two districts in the Dutch town of Zoetenneer, a suburban residential community 
near the Hague, of about 60,000 inhabitants, were invited to participate in a 
study of risk indicators for cardiovascular diseases (EPOZ study) as described 
previously. 14·16•29 Of 6.672 eligible persons, ages 5-30 years, 5.367 (2,673 males) 
participated in the study. Total cholesterol was measured in 5,089 of these (76% 
of those eligible). This group comprised 2.512 subjects ages 5-14 years (1,274 
males) and 2.577 subjects ages 15-30 years (1.245 males). 
From the 3.820 subjects ages 5-19 years who took part in the study, 596 
were selected as a random sample for yearly follow-up examinations. During 
these examinations serum total cholesterol was measured. In 1980, HDL chole-
sterol was determined for the first time in 458 subjects (244 males) of the rand-
om sample (77% of those eligible). 
Measurements 
For the determination of both total and HDL cholesterol, blood was taken 
by venipuncture from non-fasting subjects. The determinations were carried out 
in the laboratory of our department. Serum total cholesterol was measured with 
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an automated enzymatic method, utilizing the color reactions according to Kage-
yama as discussed in Ref 30. HDL cholesterol was also measured using an auto-
mated enzymatic method with the Trinder color reaction." after precipitation 
with phosphotungstate-Mg>+ .5 The determinations for total and HDL cholesterol 
were checked regularly by the WHO Regional Lipid Reference Centre in Prague 
(Dr. D. Grafnetter). Serum total cholesterol concentrations of the parents of 
the study children were determined at the initial examination. Parental chole-
sterol levels were available for 93% of the 5-14 year old subjects and for 60% 
of those 15-30 years of age. 
Body height (in ctn) and weight (in kg) were measured with the subjects 
wearing indoor clothes and no shoes. The Quetelet index. the ratio of body-
weight over height squared, was used as an index of body mass.18 Smoldng ha-
bits, physical activity. and the use of coffee. alcohol, and oral contraceptives 
were assessed by questionnaire in children ages 10 years and over. Data on smo-
Jdng habits included questions on the average amount of cigarettes smoked daily. 
A physical activity score was based on questions about regular sports activities. 
including membership in spons clubs and daily bicycling and walldng. Questions 
were asked about the average number of cups of coffee consumed daily. The 
frequency of alcohol consumption was assessed by three categories: nene. occa-
sionally and daily consumption. As this question was introduced later in the 
study, we did not obtain data on alcohol consumption for all subjects. Females 
10 years and older were asked about their menstrual history and about their 
current use of oral contraceptives. 
Data analysis 
The analysis of the distributions and determinants of serum total cholesterol 
and HDL cholesterol was based on different samples. For total cholesterol data 
on all 5,089 5 to 30-year-old subjects were used. whereas HDL cholesterol was 
analyzed for those 458 subjects of the random sample who participated in the 
study at the time HDL cholesterol was first measured. 
Mean values of total and HDL cholesterol are presented graphically as 3-year 
moving averages (Figs. 1 and 3). The 5th, 50th and 95th percentiles of the dis-
tributions are shown by 5-year age groups (Figs. 2 and 4). 
Determinants of total and HDL cholesterol levels were studied using multiple 
linear regression for males and females separately and in two age-groups (5-14 
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and 15-30 years). Total or HDL cholesterol was the outcome variable for all 
regression models. We used indicator variables to compute average cholesterol 
levels by different categories of the determinants. Body weight, Quetelet index, 
and parental cholesterol were devided into categories according to distribution 
quartiles. Each category of determinants was entered into the model as a separ-
ate indicator (O=not in this category, 1 =belongs to this category). The regression 
coefficients yielded by this model served as the difference in total or HDL cho-
lesterol between categories. An adjustment for different distributions of age 
and. if not already in the model, body weight was made for all analyses. In 
the tables and figures, P(2) refers to a two-tailed test of significance. 
RESULTS 
Mean values and distributions 
Toral cholesterol For both boys and girls. the average concentration of total 
cholesterol decreased between ages 10 and 16 (Fig. 1; detailed tables available 
upon request). The same pattern, although less distinct, was observed for the 
5th. 50th and 95th percentiles (Fig. 2). 
HDL cholesterol Mean serum HDL cholesterol levels decreased slightly for 
both boys and girls from 8 to 17 years of age (Fig. 3: detailed tables available 
upon request). Thereafter· the decrease in boys continued, whereas in girls aver-
age HDL cholesterol levels showed an increase. As a result, at 20-24 years of 
age, average HDL cholesterol levels were considerably higher in women than in 
men. The percentile distribution of HDL cholesterol showed a similar phenomenon 
(Fig. 4). 
Determinants 
Toral cholesrerol For males and females of 15 years and over. a positive 
relationship between total cholesterol and body size was found. Those in the 
upper category (according to quartiles) of body weight and Quetelet index had 
significantly higher cholesterol levels than those in the lowest one. There was 
no positive relationship between body weight and total cholesterol in subjects 
under 15 years of age (Fig. 5). 
Total cholesterol concentrations for both fathers and mothers were positively 
related to those of their children, after adjustments for age and body weight 
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TABLE 1 
Mean total cholesterol levels~ SEM (mg/100 ml), adjusted for age and 
body weight, by categories of alcohol consumption in males 
and females, 15 yrs and older 
Men women 
Alcohol n Mean SEM n Mean SEM 
consumption 
None 30 189 6.1 42 190 6.3 
occasionally 216 179(a) 2.0 254 193 2.1 
Daily 67 194(b) 4.4 28 196 6.2 
(a) P(2) < 0.10 with None as reference category 
{b) P(2) < 0.001 with Occasionally as reference category 
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TABLE 2 
Mean total cholesterol levels + SEM (mg/100 ml), adjusted for age and 
body weight, by smoking habits in males and females, 15 yrs and older 
Men Women 
Smoking habits n Mean SEM n Mean SEM 
Never 351 188 1.8 34 0 193 2.0 
Stopped 259 188 2.3 299 194 2.2 
1- 9 cig/day 212 184 2.5 317 189(a) 1.7 
10-19 cig/day 253 186 2.2 251 197(b) 2.3 
> 20 cig/day 155 187 3. 3 105 198 3.2 
{a) P(2) < 0.10 with Never as reference category 
(b) ?(2) < 0.005 with 1-9 cig/day as refe=ence category 
TABLE 3 
Mean total cholesterol levels+ SEM (mg/100 ml), adjusted for age and 
body weight, by use of oral contraceptives in women 15 years and older 
Use of oral 
contraceptives 
Yes 
No 
(a) P(2l < 0.005 
n 
476 
824 
Mean 
197 
l91(a) 
TABLE 4 
SE'M 
1.5 
1.3 
Mean total cholesterol levels+ SEM (mg/100 ml), adjusted for age and 
body weight, by having reached menarche in girls ages 11-16 years 
Menarche 
No 
Yes 
n 
312 
360 
Mean 
181 
178 
TABLE 5 
SEM 
1.6 
1.7 
Mean HDL cholesterol levels+ SEM (mg/100 ml), adjusted for age and 
body weight, by having reached menarche in girls ages 11-16 years 
Menarche 
No 
Yes 
(a) P(2) < 0.10 
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n 
25 
43 
Mean 
49 
56(a) 
SEM 
2.2 
1.4 
(Fig. 6). 
Physical activity level and coffee consumption were unrelated to serum total 
cholesterol concentrations. The relationship between total cholesterol and alcohol 
consumption is given in Table l. Men drinking daily had higher cholesterol levels 
than those drinking occasionally. Women who smoked 10 or more cigarettes a 
day had higher cholesterol levels than those who smoked less (Table 2). 
Females using oral contraceptives had significantly higher cholesterol levels 
than those who did not. even after adjustment for age. body weight. and smo-
king habits (Table 3). Total cholesterol levels did not differ between girls who 
had reached menarche and those who had not (Table 4). 
HDL cholesterol Body weight was negatively related to HDL cholesterol lev-
els in males ages 15 and over. but this negative association did not reach sta-
tistical significance in the other study groups (Fig. 7). The Quetelet index show-
ed a similar negative relation with HDL cholesterol levels. 
No associations of physical activity. smoking habits. and use of coffee. al-
cohol or oral contraceptives with HDL cholesterol levels were found. 
Girls ages 11-16 years who had had their first menstruation showed higher 
HDL cholesterol levels than those who had not yet reached menarche (Table 5). 
DISCUSSION 
Our observations confirm previous reports of a considerable decrease in total 
cholesterol between the ages of 9 and 16 years.3 ·6•10 ·21 Biological maturation 
has been implicated in this. and it has been suggested that hormonal changes 
play a part in the occurrence of this ·dip·.'·'' Although pre- and postmenarchal 
females have different sex hormone levels. we couJd not observe a significant 
difference between their total cholesterol levels. Likewise. Benion et al 2 were 
unable to find a correlation between changes in sex hormone ratios and changes 
in plasma lipids during puberty in boys. Other investigators. however. have re-
ported an association between endogenous sex hormones and plasma lipids in 
adults12·13 and in adolescent boys. 19 
Body size. expressed in various ways. is a major determinant of both total 
and HDL cholesterol. Previous studies have shown a positive association between 
body size and total cholesterol and a negative one with HDL cholesterol levels, 
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especially in adults. 11 •25 •27 In our study. we found body weight to be a deter-
minant of total cholesterol in the older age groups but not in the younger ones. 
This suggests that early in life determinants of total cholesterol may differ from 
those operating later in life. e.g., those related to physical maturation. Our ob-
servations indicate that this may also apply to HDL cholesterol. The only deter-
minant that is common to children and young adults is parental cholesterol lev~ 
els. This confirms a report by Morrison et al., 22 who observed. both in children 
who lived with their parents and in those who did not, positive correlations 
between their cholesterol levels and those of their parents. In a separate ana-
lysis. we did not fmd evidence for a multiplicative effect of paternal and ma-
ternal cholesterol levels on those of their children. 
An interesting fmding is that after the age of about 17 years. average HDL 
cholesterol increases in women but decreases in men. This leads to a considerable 
gender difference in HDL cholesterol levels in early adulthood.1 From a preven-
tive point of view. it may be of imponance that men showed a significant ne-
gative relationship between HDL cholesterol and body weight. as has been ob-
served elsewhere. 11 
We cannot confirm previous findings of an association between physical ac-
tivity and total or HDL cholesterol. This may be due to dilution of the 'true· 
relationship towards the null value. as a result of random error in the measure-
ment of physical activity. In the case of HDL cholesterol. it may also be due 
to the relatively small numbers. 
The evidence concerning the relationship between oral contraceptive use and 
cholesterol concentration is equivocal. Our finding of a relationship between 
such contraceptives and total cholesterol and total cholesterol and the absence 
of a relationship with HDL cholesterol confirms a report by Wallace et al. 31 
However. this does not warrant a firm conclusion about the effects of oral con-
traceptives on cholesterol levels. as the different compositions of oral contra-
ceptives were not taken into account. 
We found no association between coffee consumption and cholesterol levels. 
and this confirms our previous report on adults from the same population.16 
Our observations on the relationship between cholesterol levels and either alco-
hol consumption or smoking habits are at variance with some other 
reports.7 ·9·23 ·25 We did not observe a positive relationship between HDL chole-
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sterol and alcohol consumption. This might be due to the fact that we only re-
ferred to the frequency of drinking and not to the amount consumed. 
In summary. we found differences in HDL and total cholesterol levels by 
age and gender. The determinants of these levels seem to be different for child-
ren and adults. This underscores the important role of growth and maturation 
in determining lipid levels. Further investigation of the impact of factors related 
to physical maturation on lipid metabolism seems a promising way to elucidate 
the determinants of cholesterol levels in childhood. 
ACKNOWLEDGMENTS 
We are grateful to all the young people and their parents who participated 
in this study. We thank Ria Rijneveldshoek and our co-workers in the EPOZ 
examination center. We gratefully acknowledge the contribution of Dr. Frank 
Klein. Jolanda Bekker. and Leo Muller to this work. 
98 
REFERENCES 
I Beaglehole R. Trost DC. Tamir I, Kwiterovich P, Glueck CJ. Insull W. and 
Christensen B. Plasma high-density lipoprotein cholesterol in children and 
young adults. The lipid research clinics program prevalence study. Circulation 
I 980:62[suppl IV]:83-92. 
2 Benion U. Howard BV. and Bennett PH. Pubertal changes in plasma lipids 
and lipoproteins. lack of correlation with plasma estradiol/testosterone. Clin 
Res 1978:26(2): 126A. 
3 Berenson GS. "Cardiovascular risk factors in children". New York. Oxford 
University Press. 1980. 
4 Berenson GS. Srinivasan SR. Cresanta JL. Foster TA. and Webber LS. Dynamic 
changes of serum lipoproteins in children during adolescence and sexual 
maturation. Am J Epidemiol 1981;113:157-70. 
5 Burstein M. Scholnick HR. and Morfin R. Rapid method for the isolation of 
lipoproteins from human serum by precipitation with polyanions. J Lipid Res 
1970: II :583-95. 
6 Cresanta JL. Srinivasan SR. Foster TA. Webber LS. and Berenson GS. Serum 
lipoprotein levels in children: epidemiologic and clinical implications. J Chron 
Dis 1982:35:41-51. 
7 Criqui MH. Wallace RB. Heiss G. Mishkel M. Schonveld G. and Jones GTL. 
Cigarette smoking and plasma high-density lipoprotein cholesterol. The lipid 
research clinics program prevalence study. Circulation !980:62[suppi!Vj:70-6. 
8 Dawber TR. "The Framingham Study". Cambridge. Harvard University Press, 
1980. 
9 Castelli WP. Doyle IT. Gordon T. Hames CG. Hjortland MC. Hulley SB. Kagan 
A. and Zukel. WJ. Alcohol and blood lipids. Lancet ii:l977: 153-5. 
I 0 Frerichs RR. Srinivasan SR. Webber LS. Berenson GS. Serum cholesterol and 
triglyceride levels in 3.446 children from a biracial community. The Bogalusa 
heart study. Circulation 1976:54:303-9. 
II Glueck CJ. Taylor HL. Jacobs D. Morrison JA. Beaglehole R. Williams OD. 
Plasma high-density lipoprotein cholesterol: association with measurements of 
body mass. Circulation 1980:62[suppl IV]:62-9. 
12 Heller RF. Miller NE. Lewis B. Vermeulen A. Faimey A. James VHT. Swan V. 
99 
Associations between sex honnones. thyroid honnons and lipoproteins. Clin 
Science 1981:61:649-51. 
l3 Hjortland MC. McNamara PM. Kannel WB. Some atherogenic concomitants of 
menopause: The Framingham Study. Am J Epidemiol 1976;103:304-1 l. 
14 Hofman A. KJein F. Valkenburg H.A. Natural history of serum cholesterol in 
childhood. Anery 1980:8: !57-63. 
15 Hofman A. Valkenburg HA. Detenninants of change in blood pressure during 
childhood. Am J Epidemiol 1983:117:735-43. 
16 Hofman A. Van l.aar A. Klein F. Valkenburg HA. Coffee and cholesterol. New 
Eng! J Med 1983:309:1248-9. 
17 Keys A. Longstreet Taylor H. Blackburn H. Brozek J. Anderson IT. Simonson 
E. Mortality and coronary heart disease among men studied for 23 years. Arch 
intern Med 1971:128:201-14. 
18 Khosla T. Lowe CR. Indices of obesity derived from body weight and height. 
Brit J prev soc Med 1967:21:122-8. 
19 l..askarzewski PM. Morrison JA. Gulai J. Orchard T. Khoury P. Glueck CJ. 
High and low density lipoprotein cholesterols in adolescent boys: relationships 
with endogenous testosterone. estradiol. and Quetelet index. Metabolism 
1983:32:262-71. 
20 Miller GJ. Miller NE. Plasma high-density-lipoprotein concentration and 
development of ischaemic heart-disease. Lancet 1975:i: 16-9. 
21 Morrison JA. deGroot !. Edwards BK. Kelly KA. Rauh JL. Mellies M. Glueck 
CJ. Plasma cholesterol and triglyceride levels in 6775 school children. aged 
6-17. Metabolism 1977:26:1199-1211. 
22 Morrison JA. Kelly K. Horvitz R. Khoury P. Laskarzewski PM. Mellies MJ. 
Glueck CJ. Parent-offspring and sibling lipid and lipoprotein associations 
during and after sharing of household environments: the Princeton School of 
District Family Study. Metabolism 1982:31: 158-66. 
23 Morrison JA. Kelly K. Mellies M. deGroot I. Khoury P. Gartside PS. Glueck 
CJ. Cigarette smoking. alcohol intake. and oral contraceptives: relationships 
to lipids and lipoproteins in adolescent children. Metabolism 1979:28: l 166-70. 
24 Morrison JA. Laskarzewski PM. Rauh JL. Brookman R. Mellies M. Frazer M. 
Khoury P. deGroot I. Kelly K. Glueck CJ. Upids. lipoproteins. and sexual 
maturation during adolescence: the Princeton maturation study. Metabolism 
100 
1979:28:641-9. 
25 Pincherle G. Factors affecting the mean serum cholesterol. J Chron Dis 
1971:24:289-97. 
26 Pooling project research group. Relationship of blood pressure. serum 
cholesterol. smoking habit. relative weight and ECG abnormalities to incidence 
of major coronary events. J Chron Dis 1978:31:225-306. 
27 Rifkind BM. Begg T. Relationship between relative body weight and serum 
lipid levels. Brit Med J 1966:2:208-10. 
28 Salonen JT. Puska P. Relation of serum cholesterol and triglycerides to the 
risk of acute myocardial infarction. cerebral stroke and death in Eastern 
Finnish male population. lnt J Epidemiol 1983:12:26-31. 
29 Valkenburg HA. Hofman A. Klein F. Groustra FN. Een epidemiologisch 
onderzoek naar risico-indicatoren voor hart- en vaatziekten (EPOZ).L 
Bloeddruk. serumcholesterolgehalte. Queteletindex en rookgewoonten in een 
open bevolking van vijf jaar en ouder. Ned T Geneesk 1980:124:183-9. 
30 Van Gent CM. Van der Voort HA. De Bruyn AM. Klein F. Cholesterol 
determinations. A comparative study of methods with special reference to 
enzymatic procedures. Clin Chim Acta 1975:75:243-51. 
31 Wallace RB. Hoover J. Barrett-Connor E. Rifkind BM. Hunninghake DB. 
Mackenthun A. Heiss G. Altered plasma lipid and lipoprotein levels associated 
with onal contraceptive and oestrogen use. Lancet 1979:ii: 111-5. 
101 
Appendix 2 
DO ORAL CONTRACEPTIVES INCREASE BLOOD PRESSURE AND 
SERUM TOTAL CHOLESTEROL IN YOUNG WOMEN? 
W.A.H.J. van Stiphout 
D .E. Grobbee 
A. Hofman 
A.M. de Bruijn 
Department of Epidemiology. Erasmus University Medical School. 
PO Box 1738. 3000 DR Rotterdam. The Netherlands 
l Submitted] 
102 
Summary 
The effects of the use of oral contraceptives on serum lipids and blood pres-
sure were studied in young women who participated in a longitudinal survey of 
risk factors for coronary heart disease in the Netherlands. During follow-up 53 
women started to use oral contraceptives. The year before they started they 
were 14 to 24 years of age. and they continued using oral contraceptives for 
at least two subsequent years. From 53 age-matched control subjects. who did 
not use oral contraceptives, data were obtained for the same follow-up period. 
Women on oral contraceptives showed a significantly greater rise in serum total 
cholesterol levels than the reference subjects (14 mg/100 ml/2 year vs 4 mg/100 
ml/2 year). They also showed a somewhat greater increase in systolic blood pres-
sure (4. 7 mmHg/2 year vs 2.1 mmHg/2 year). but this difference was not statis-
tically significant. In a separate analysis oral contraceptive users were divided 
in those who used oral contraceptives with 50 tJ-g of ethinylestradiol or more 
and those who used oral contraceptives with less than 50 /)-g . There were no 
significant differences in the increase in total cholesterol or blood pressure 
between these two groups of oral contraceptive users. 
These findings suggest that the use of oral contraceptives may be associated 
with an enhanced rise in total cholesterol. and perhaps in blood presstl're. during 
adolescence. 
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INTRODUCTION 
Since the introduction of the oral contraceptive pill in the early sixties, 
repeatedly attention has been focussed on its possible harmful side-ef-
fects.L2 Especially. the relation between oral contraceptives and cardiovascular 
diseases has been studied. 2-6 Also the putative association between oral contra-
ceptives and risk factors for heart disease, like blood pressure7·8•9 and serum 
lipids9-12 has been the subject of investigations. The results of these studies, 
however. have been equivocal. and appear to depend on the age of the study 
population. the hormonal composition of the contraceptive pill, and the place 
and time of the study. The study reported here differs from some former ones 
in that it deals with young women, who started the use of oral contraceptives 
during a follow-up study. 
SUBJECTS AND METHODS 
Population 
From 1975 to 1978. all residents aged 5 year and older living in two districts 
of Zoetermeer. a suburban town near The Hague in the Netherlands. were asked 
to participate in a study for risk indicators of cardiovascular disease (EPOZ), 
as described earlierY From the 4,649 subjects aged 5-19 years who took part 
in the study (82% of those eli gable). a random sample of 596 children (296 fe-
males) was selected for yearly follow-up. 
Measurements 
During the yearly examinations body height (in em) and weight (in kg) were 
measured with the study subjects wearing indoor clothes without shoes. Blood 
pressure was measured using a random zero sphygmomanometer, twice in sitting 
position. and blood was taken by venipuncture from the non-fasting subjects. 
Serum total cholesterol was measured with an automated enzymatic method. util-
izing the color reactions according to Kageyama. 14 Serum HDL cholesterol was 
also measured using an automated enzymatic method with color reaction accord-
ing to Trinder. after precipitation with phosphotungstate-Mg"+ _15 As the meas-
urement of HDL cholesterol was initated only in 1980, fewer data were avail-
able. The determinations of both total and HDL cholesterol were carried out in 
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the laboratory of our department, which participates in the lipid standardization 
program of the WHO Regional Lipid Reference Centre in Prague (Dr. D. Graf-
netter). 
Each year the respondents completed a questionnaire on smoking habits, use 
of alcoholic beverages and use of coffee. Girls were also asked about their men-
strua] history. pregnancy and use of oral contraceptives. 
Selection of persons 
During follow-up I 0 I women indicated oral contraceptive use at least at one 
yearly examination. Of 53 women information on serum lipids and blood pressure 
was available both of the year before the start of use and two subsequent years 
of use. From the remainder of the cohort. i.e .. those who never used oral con-
traceptives. 53 reference subjects (controls) were selected. matched for age. 
They were not pregnant and they participated in at least three consecutive an-
nual examinations. In figure I. the design of this study is graphically displayed. 
At year 0. which may be any chronological year during follow-up. the "cases" 
were not yet using oral contraceptives and they were not pregnant either. At 
year I. the cases used oral contraceptives for the first time and they still used 
them at year 2. Control women did not use oral contraceptives. nor were they 
pregnant at year 0, 1 or 2. In table 1. baseline characteristics of fUture users 
of oral contraceptives and reference women are given. 
TABLE 1 
Baseline characteristics (with standard deviations) of 
users and non-users of oral contraceptives 
Users Non-users 
(n=53J (n,.53) 
Age (years) 17.8 I 2.3 l 17.8 I 2.3) 
Body weight (kg) 58.2 I 10.8) 59.5 I 9. 5) 
Quetelet index (kg/m2) 20.6 ( 3. 5) 20.9 I 2. 6 l 
Cigarette smoking I%) 45 23 
Total cholesterol (mg/100 m1) 180.2 (27.7) 188.8 I 26.8) 
HDL cholesterol (mg/100 ml) • 50.4 I 13.1 l 51.7 I 11.5 l 
Systolic blood pressure (m.m.Hg) 110.1 (11. 7) 114.1 ( 12.6) 
Diastolic blood pressure (mmEg) 67.3 ( 8. 5) 67.3 I 9.1 l 
• based on 25 use=s and 39 non-users 
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Data analysis 
Our data analytic approach was two-fold. Firstly, average total and HDL 
cholesterol concentrations and blood pressure values were compared between 
users and non-users at year 0, I and 2. Secondly. the change in cholesterol 
and blood pressure over the two years of follow-up was compared between users 
and non-users. An adjustment for different distributions of age and body weight 
was made in all analyses. For this purpose we used multiple linear regression, 
in which serum lipids or blood pressure (or the change in these characteristics) 
were the dependent variables. Indicator variables were used to compute average 
lipid or blood pressure levels (or the average change in these variables) by the 
comparison groups. 16 The regression coefficients yielded by this model served 
as the adjusted difference in cholesterol or blood pressure level (or in change 
of cholesterol and blood pressure) between the comparison groups. 
I Year 0 1 2 
Cases (n=53) oc- OC+ OC+ 
Controls (n=53) oc- oc- oc-
Fig. J. Design of the study. 
RESULTS 
Average levels 
The average levels of total and HDL cholesterol in year 0, 1 and 2 for both 
users of oral contraceptives and non-users are given in fig 2. No significant 
differences were observed in either total or HDL cholesterol in any year. Also, 
systolic and diastolic blood pressure levels during year 0, 1 and 2, were not 
significantly different between users and non-users (Fig. 3). 
Change in level 
The changes in serum total and HDL cholesterol, and in systolic and dias-
tolic blood pressure in the two years of follow-up for users and non-users of 
oral contraceptives are given in table 2. The difference in the change of total 
cholesterol between users and non-users was 9.8 mg/100 ml (95% confidence 
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interval: 0.1 - 19.6). For HDL cholesterol this difference was -2.7 mg!JOO ml 
(95% Cl: -8.6- 3.3). The increase in systolic blood pressure was 2.6 mmHg larger 
(95% Cl: -1.8 - 6.9) in users of oral contraceptives than in non-users, while 
the change in diastolic pressure did not differ between users (0. I mmHg) and 
non-users (0.0 mmHg). A separate analysis in which women who used oral con-
traceptives with an oestrogen dose of ~50 /).g were compared with women who 
used <50 /).g . showed non-significant differences in the change in total chole-
sterol and systolic blood pressure (table 3). 
TOTAL CHOLESTEROL (mg/dl) 
200 
190 
"'" 180 
HO 
;;;;;; 
160 mm 
)-CarO year1 year2 
HDL CHOLESTEROL (mg/dl) 
60 
50 
40 
30 
Illi] users of OC 0 non users 
year2 
Fig. 2. Average levels of total and HDL cholesterol in mg/100 ml (with S.E.M.) 
in users of oral contraceptives and non users, during year 0. 1 and 2. 
SYSTOLIC BLOOD PRESSURE (mmHg) 
120 
110 
100 
90 
year 0 
DIASTOLIC BLOOD PRESSURE (mmHg) 
70 
60 
50 
40 
.:::: 
:::: 
"" 
"" 
"" 
:::: 
:::: 
;::: 
:::: 
:::: 
yearO = ye<Jr 1 
rulill users of OC 0 non users 
Fig. 3. Average levels of systolic and diastolic blood pressure (with S.E.M.) in 
users of oral contraceptives and non users. during year 0. I and 2. 
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TABLE 2 
Average change * in total and HDL cholesterol and systolic and diastolic 
blood pressure in two years of follow up, for users and 
non-users of oral contraceptives 
Users 
ln·53) 
Total cholesterol (mg/100 ml) 14.0 
HDL cholesterol (mg/100 ml) 0.3 
Systolic blood pressure (mmHg) 4.7 
Diastolic blood pressure (m.mHg) 0.1 
* Adjusted for age and body weight 
TABLE 3 
Non-users ?(2) 
(n=53) 
4.2 0. 05 
3.0 0.38 
2.1 0.25 
0.0 0.99 
Average change* (with S.E.M.) in total cholesterol and 
blood pressure for users of oral contraceptives, 
with either ~ 50 ~9 or < 50 ~g ethinylestradiol 
Total cholesterol (mg/100 ml) 
systolic blood pressure (m.mHg) 
* Adjusted for age and body weight 
)_,. 50 f.l9 
(n=l6) 
14.4 16.9) 
5 .a I 2. 5) 
DISCUSSION 
< 50 ~9 
(n=22) 
15.5 15.2) 
3.1 I 2.51 
This study comprises both a cross-sectional and a longitudinal comparison of 
serum lipids and blood pressure between users of oral contraceptives and non-
users. Before we base our inference on these findings. we need to comment on 
two observations: namely. (I) there were initial differences between users and 
non-users and (2) the results of the cross-sectional and the longitudinal analysis 
were different. 
Although the initial differences in serum total cholesterol and systolic blood 
pressure between users and non-users were not statistically significant. they 
might point to a limited comparability of users and non-users of oral contra-
ceptives at baseline. Women who are going to use oral contraceptives may be 
108 
different in aspects relevant for serum lipids and blood pressure, from women 
who do not. An explanation for the initial differences may be that young women 
who are going to use oral contraceptives are biologically more mature than those 
who are not. We looked at menarchal age. as a measure for maturity. but the 
average age at menarche was the same for both users and control women. The 
frequency of cigarette smoking was somewhat higher among the future users of 
oral contraceptives smokers. than among the control women (table 1). This is 
in agreement with previous findings of a higher prevalence of smokers among 
oral contraceptive users. 5 However. as smoking was positively associated with 
total cholesterol values in our data. this would have caused a difference in the 
opposite direction. Selection bias could have occurred if the control women were 
excluded from oral contraceptives because of elevated cholesterol or blood pres-
sure levels. However. all initial blood pressure and cholesterol levels were within 
normal ranges in both groups. Moreover. any bias introduced by exclusion of 
subjects with elevated blood pressure for oral contraceptive use would again 
have acted against a difference in blood pressure between the groups. And al-
though blood pressure is regularly measured by general practioners in the Neth-
erlands. serum cholesterol concentrations hardly ever are. Therefore. most prob-
ably the observed initial differences are due to chance. but they de obscure 
possible differences at year 1 and 2. We are therefore inclined to favor the 
longitudinal analyses for inference. and to adjust for possible confounding factors 
that influence change in the risk factors. Possible confounders that were taken 
into account were change in weight and change in smoking behavior. There were 
no differences between the two groups of women in change of body weight or 
smoking status. Although this is not an experimental study and therefore bias 
still has to be considered. we feel confident to conclude that young women who 
start using oral contraceptives may experience a larger rise in serum total cho-
lesterol. and perhaps also in blood pressure. than young women who do not. 
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Summary 
The associations between pregnancy and serum lipids were investigated in a 
cohort of 831 Dutch women. initially aged 5-19 years. These women were exam-
ined yearly for an average period of 6 years. as part of a longitudinal survey 
of risk factors for coronary heart disease. During this period 62 women became 
pregnant and their serum total and HDL cholesterol levels were compared to 
that of an age-matched reference series of non-pregnant women. derived from 
the same cohort. Pregnant women showed higher total cholesterol levels (235 + 
7.4 mg/JOO m!) than non-pregnant women (205 + 2. 7 mg/JOO ml). Pregnant women 
also had higher levels of HDL cholesterol (66 + 2.1 mg/JOO ml) than their ref-
erents (57.± 1.0 mg/100 ml). Total and HDL cholesterol increased with duration 
of pregnancy. When serum lipid levels of pregnant women were compared to 
the levels one year before and one year after pregnancy. it was observed that 
the year after pregnancy HDL cholesterol levels dropped below pre-pregnancy 
concentrations. At the final examination. women who ever had been pregnant 
were compared with women who never had been pregnant. Those who ever had 
been pregnant showed lower HDL cholesterol levels than those who never had 
been pregnant. The difference was most marked in users of oral contraceptives. 
These observations suggest that serum total and HDL cholesterol are elevated 
during pregnancy. probably due to hormonal changes. They furthermore point 
to a possibly lowering effect of parity on HDL cholesterol. These fmdings may 
help to explain the reported positive association between parity and the occur-
rence of cardiovascular diseases. 
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INTRODUCTION 
There appears to be growing agreement with the view that atherosclerosis 
has its onset early in life1 and that preventive action should be focussed on 
youngsters. 2 ln adults serum lipids have been found to. be highly associated with 
coronary atherosclerosis. 3 RecentJy. postmortem studies in youngsters revealed 
evidence for an association of serum lipids and atherosclerosis early in life. 4 
Inquiries into the determinants of serum lipid levels in young people may there-
fore yield insight into the early pathogenesis of atherosclerosis. 
In women. honnonal status has been implicated in both serum lipids and car-
diovascuiar disease. Several studies have shown an increase of serum lipids.5·7 
as well as a strong increase in the occurrence of cardiovascular disease6-10 
after menopause. Studies of the association between parity and cardiovascular 
disease have shown equivocal results. In some investigations an increased cardio-
vascular risk in multiparous women was observed.7·10·II whereas in other studies 
parity was not associated with cardiovascular disease. 12 ·13 Beard et al. observed 
an increased cardiovascular risk for women who had their first pregnancy at 
an early age. 14 Pregnancy has been suggested to increase phospholipids. trigly-
cerides. total cholesterol. low density lipoprotein (LDL) and high de<~sity lipo-
protein (HDL) cholesterol_!'·" However. there is only limited evidence available 
from prospective follow-up studies with measurements of serum lipids both before 
and after pregnancy. 21 
To investigate the relation between pregnancy and serum lipids, we studied 
62 women who became pregnant during a follow-up study of cardiovascular risk 
factors in young people. 
SUBJECTS AND METHODS 
Population 
From 1975 to 1978. all 5.670 residents aged 5 - 19 years and living in two 
districts of Zoetermeer. a suburban town near the Hague in the Netherlands. 
were asked to participate in a study for risk indicators of cardiovascular disease 
(EPOZ). as described earlier.22 From the 4.649 subjects who took part in the 
study (i.e .. 82 per cent of those eligible). those who had levels of one or more 
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of the cardiovascular risk indicators (blood pressure. serum total cholesterol. 
Quetelet index. cigarettes smoking) in the upper ten percent of the distribution 
at the initial examination and those who served as a reference group taken at 
random from the remaining part of the initially examined children were selected 
for yearly follow-up. A total of 1.597 youngsters. among whom were 831 women. 
were re-examined each year and the average follow-up period was 6 years. 
Measurements 
During the yearly examinations body height (in ctn) and weight (in kg) were 
measured with the subjects wearing indoor clothes without shoes. blood pres-
sure was measured with a random-zero device. and blood was taken by venipunc-
ture from the non-fasting subjects. Serum total cholesterol was measured with 
an automated enzymatic method. utilizing the colour reactions according to Kage-
yama. 23 Serum HDL cholesterol was also measured using an automated enzymatic 
method with colour reaction according to Trinder. after precipitation with phos-
photungstate-Mg'+ .24 Measurements of HDL cholesterol were started only in 
1980. The determinations of both total and HDL cholesterol were carried out in 
the laboratory of our department and were within the limits of the standardi-
sation program of the WHO Regional Lipid Reference Centre in Prague (Dr. D. 
Grafnetter). throughout the entire study period. Every year the r~spondents 
filled in a questionnaire on smoking habits. use of alcoholic bevarages and use 
of coffee. Girls were also asked about their menstrual history. pregnancy and 
use of oral contraceptives. 
Comparison groups 
For this paper different analyses were made based on the following compa-
risons: 
Currently pregnant versus non pregnant women During the follow-up period 
62 women had their first pregnancy at the time of the annual examinativn. Their 
ages ranged from 18-28 years (mean 23 years. SD 2.5 years). For each pregnant 
woman three non-pregnant reference women matched for age were selected. 
Serum total cholesterol levels were available for 58 pregnant women and 165 
reference women. Serum HDL cholesterol levels were determined in 45 pregnant 
and 155 reference women. In a separate analysis. a subdivision of the pregnant 
women in three groups was made according to the duration of their pregnancy. 
Before, during and after pregnancy Depending on the moment of their preg-
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nancy during the follow-up, some women had also had an annual examination 
the year before and/or the year after their pregnancy. In this analysis, only 
women who had lipid measurements before, during and after their pregnancy 
were included. This applied to 30 women for serum total cholesterol and to 22 
women for serum HDL cholesteroL 
Ever versus never pregnant women At the last examination during the fol-
low-up 58 women stated that they ever had been pregnant, but were not preg-
nant now. Their ages ranged from 21 to 30 years at the last examination. There 
were 187 women of the same ages, who never had been pregnant. Serum total 
and HDL cholesterol were measured at the last examination in 53 women who 
ever had been pregnant. and in 179 women who never had been pregnant. Se-
parate comparisons were made for current users versus non-users of oral contra-
ceptives. 
Data analysis 
Average values of total and HDL cholesterol were compared between the 
groups. An adjustment for different distributions of age and body weight was 
made in all comparisons. For this purpose a multiple linear regression model 
was used, in which serum total or HDL cholesterol was the outcome variable 
and an indicator variable by comparison group was added as the in9ependent 
variable. The regression coefficients yielded by this model served as the adjusted 
difference in total or HDL cholesterol between comparison groups. In the tables 
and figures p-values refer to a two-tailed test of significance. 
RESULTS 
Currently pregnant versus non pregnant women 
In table J average total and HDL cholesterol levels. and the ratio of HDLI 
total cholesterol, for pregnant women and their matched controls are given. 
Pregnant women had significantly higher levels of both total and HDL chole-
steroL However, the ratio of HDL!total cholesterol was similar for pregnant wo-
men and their reference subjects. Separate comparisons with control women 
who used or did not use oral contraceptives did not materially change the re-
sults. 
In figure J total and HDL cholesterol levels. and their ratio, adjusted for 
!16 
TABLE 1 
Average total and HDL cholesterol (mg/100 ml) and the ratio of 
HDL/total cholesterol (%), in pregnant women and 
matched controls (EPOZ study, 1975-1985) 
Preonant women Non oreonant controls 
N Mean SEM 
Total cholesterol 57 235 7.4 
HDL cholesterol 45 66 2.1 
HDL/total cholesterol 45 29 0.9 
N 
165 
155 
155 
Mean SEM 
205 
57 
2B 
2.7 
1.0 
0.5 
* Adjusted for differences in age and body weight 
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Fig. !. Total and HDL cholesteroL and the ratio of HDL!total cholesterol (with 
SEM) in pregnant women during their first. second and third trimester. EPOZ 
study. !975-1985. * p < 0.01. ** p < 0.001. with first trimester as reference 
category. 
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Fig. 2. Total and HDL cholesterol. and the ratio of HDL/total cholesterol (with 
SEM) in women before. during and after their pregnancy. EPOZ study. 
1975-1985. * p < 0.05. ** p < 0.01. *** p < 0.001. with before as reference 
category. 
TABLE 2 
Average total and HDL cholesterol {mg/100 ml) and the ratio of HDL/total 
cholesterol (%I in women who were ever and who were never pregnant, 
by use of oral contraceptives (EPOZ study, 1975-1985) 
Ever E:reqnant Never oreqnant 
N Mean SEM N Mean SEM p• 
Non-users 
Total cholesterol 31 212 7.3 70 197 4.6 0.16 
BDL cholesterol 31 51 2.3 70 56 1.3 0.10 
HDL/total cholesterol 31 25 1.3 70 29 0.8 0.008 
OC-users 
Total cholesterol 22 218 8.3 109 211 3.3 0.44 
HDL cholesterol 22 46 2.2 109 58 1.3 < 0.001 
HDL/total cholesterol 22 22 1.5 109 28 0.6 < 0.001 
* Adjusted for differences in age and body weight 
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Fig. 3. Total and HDL cholesterol. and the ratio of HDL!total cholesterol (with 
SEM) in women who ever but not currently were pregnant, and in women who 
never were pregnant. EPOZ study. 1975-!985. *** p < 0.001. 
age and body weight. are given for women in their first. second and third tri-
mester of pregnancy. Both total and HDL cholesterol showed an increase with 
the duration of pregnancy. The ratio of HDL!total cholesterol showed a decline 
during pregnancy. 
Before, during and after pregnancy 
In figure 2 serum total and HDL cholesterol levels are given for 30 and 22 
women. respectively. of whom lipid measurements were available both the year 
before and the year after the examination during which they were pregnant. 
Serum total cholesterol rose significantly during pregnancy and dropped to pre-
pregnancy values again. Serum HDL cholesterol showed a small rise during preg-
nancy. but post-pregnancy levels fell below the levels observed before pregnancy. 
The ratio of HDL!total cholesterol. also shown in figure 2. was significantly 
lower the year after pregnancy as compared to concentrations before pregnancy. 
Ever versus never pregnant women 
Figure 3 shows serum total and HDL cholesterol at the final examination. 
adjusted for age and body weight. in women who were ever and those who were 
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never pregnant. No significant differences were observed in total cholesterol 
levels between those who ever and those who never were pregnant. HDL chole-
sterol was significantly lower in those who ever were pregnant. A separate ana-
lysis showed that the differences were mainly observed in those who currently 
used oral contraceptives (table 2). The ratio of HDL/total cholesterol. also shown 
in figure 3, was significantly lower for those who ever were pregnant. whether 
or not they currently used oral contraceptives (table 2). 
DISCUSSION 
This study gives both cross-sectional and longitudinal data of the association 
of pregnancy with serum total and HDL cholesterol in a population of young 
women. Although many studies have investigated the effect of pregnancy on 
serum lipids. 15•11 only one study'1 included measurements of total cholesterol 
before. during and after pregnancy. whereas HDL cholesterol was not measured. 
Higher levels of total cholesterol in pregnant women, as compared to post-
pregnancy levels or non-pregnant women. have been described before. 1&-21 The 
increase of total cholesterol with the duration of pregnancy suggests that hor-
monal alterations may be implicated. Punnonen25 found a significant correlation 
between the changes in serum total cholesteroJ and oestradiol levels in pregnant 
women. Some investigators observed an increase in serum HDL cholesterol during 
pregnancy. nuo whereas others did not. 19 In our study there was no overall 
difference in the ratio of HDUtotal cholesterol betv.>een pregnant and non-preg-
nant women. However. during the last pregnancy trimester this ratio appears to 
be decreased. Oliver and Boyd16 and Watson 17 also noted a change in the alpha-
/beta lipoprotein ratio (HDLILDL) in pregnant women. With increasing duration 
of pregnancy. this ratio decreased. 
A new and unexpected finding is the decreased HDL cholesterol the year 
after pregnancy. This was not due to changes in laboratory methods over time. 
as we discussed on the basis of a preliminary report elsewhere. 26 Differences 
in age and body weight also could not explain the decrease. as adjusting for 
these characteristics did not alter the results. The proportion of users of oral 
contraceptives was unequal. the year before and after pregnancy. When control-
ling for this. HDL cholesterol was lower the year after pregnancy. compared to 
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the year before. The percentage smokers was the same the year before and the 
year after pregnancy. Both smokers and non-smokers showed a decrease in HDL 
cholesterol the year after pregnancy. The analysis in which we compaped women 
who had ever been pregnant with women who had never been pregnant. confir-
med the negative association between HDL and pregnancy. Especially wom~n on 
oral contraceptives. who ever were pregnant. showed lower HDL cholesterol 
levels than women who never were pregnant and also used oral contraceptives. 
The ratio of HDL!total cholesterol was significantly lower in all women who 
ever were pregnant. Several studies have shown a relation betv.reen parity and 
coronary heart disease.7 · 10· 11 However. Httle research has been done on inter-
mediate factors. such as lipid levels. This study suggests that women who ex-
perienced pregnancy have lower HDL cholesterol levels and may therefore be 
at higher risk of coronary heart disease. than women who never were pregnant. 
It deserves further investigation to elucidate the relation between parity. HDL 
cholesterol and coronary heart disease. 
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Summary 
Seventeen constitutionally tall prepubertal girls. aged 10 to 14 years. were 
treated with large doses of ethinyl estradiol (EE) to reduce their final height. 
The serum concentration of cholesterol. triglyceride. and apolipoproteins before 
and after four to 17 months of treatment were compared with the same variables 
in a reference group. initially matched for bone age and height. In the patients. 
cholesterol rose by 24% (l.l.± 0.8 mmoi/L). triglyceriden by 105% (0.97 .± 0.70 
mmoi/L). LDL apo B by 48% (27 .± 19 mg/dL). apo A-1 by 45% (62 + 17 mg/dL). 
and apo A-ll by 21% (12 + 11 mg/dL). In the reference group. none of these 
variables changed significantly. The ratio of LDL apo B/apo A-l remained con-
stant in both groups. 
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INTRODUCTION 
Excessively tall girls may be treated with high doses of estrogens in an 
attempt to increase their rate of bone maturation and so to reduce their fmal 
adult height. Possible side effects of the administration of estrogens could be 
harmful or beneficial. Small quantities of estrogens given to postmenopausal 
women may give some protection against cardiovascular death. 1 
Protection by estrogens against vascular disease has been attributed to be-
neficial effects on circulating lipoproteins. both Low Density Lipoproteins (LDL)2 
and High Density Lipoproteins (HDL).3 Recently. attention has been focused on 
apolipoproteins as predictors of atherosclerotic disease.4 
We investigated the effect of EE. given in a dose of 0.2 mg per day to 
constitutionally tall girls on the apolipoproteins of HDL (apo A-! and apo A-ll) 
and of LDL (apo B) and on total serum cholesterol and triglyceride. We compared 
changes in lipoprotein levels in these girls with those from another group of 
tall girls that did not receive estrogens. 
SUBJECTS AND METHODS 
Seventeen apparently healthy. tall prepubertal girls. aged I 0 to 14 years. 
were studied. They received 0.2 mg per day EE per os for about 2 years. During 
5 days each month they also took I 0 mg per day medroxyprogesteronacetate 
(MPA). Postabsorptive blood samples were taken at the start and at the end of 
a period varying from 4-17 months. 
Seventeen reference subjects were partiCipants of a longitudinal study of 
risk factors of cardiovascular disease in 1.600 youngsters. initially aged 5-19 
years and selected from an open population-' Each year they underwent an exam-
ination in which their body weight and height were measured and a venous blood 
sample was taken to measure serum lipoproteins. Out of all female participants. 
controls were individually matched with the patients for chronological age ( + 9 
months). and bone age ( + 9 months). From each age-category that matched the 
patient. the tallest girl was included. Skeletal age in all subjects was estimated 
according to Tanner.6 
Serum concentrations of cholesterol were determined according to Abell et 
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al.7 of triglyceride according to Giegel et al. 8 and of apolipoproteins by means 
of radial immunodiffusion against monospecific antibodies according to Cheung 
and Albers (for apo A-I and apo A-1!)9 and according to Havekes et al. (for 
LDL-apo B). 10 
RESULTS 
Table 1 shows mean initial and final values of the clinical and biochemical 
measurements in the two groups. It appears that the two groups were incomple· 
tely matched with respect to tallness. There were also differences in the initial 
values of the apolipoproteins. although the serum cholesterol levels were similar. 
All lipid and apolipoprotein levels increased considerably in the experimental 
group. but not in the reference group. In order to compare the changes in the 
two groups. we performed multiple linear regression analysis with initiaJ height. 
weight. chronological age. and Jevel of lipid fractions as possibie confounders in 
the model. Table 2 shows average values of changes in total cholesterol and 
apolipoproteins in patients and a reference group controlled for these variables. 
The differences between patients and reference group in changes of total cho-
lesteroL apolipoprotein A-L A-U and B were highly significant. Variations in 
the length of the observation period had no significant influence on the outcome. 
neither had the relation of sampling time to the pseudomenstrual cycle. 
DISCUSSION 
The increase in lipid and apolipoprorein levels in the experimental group 
was far in excess of the changes in the reference subjects. It was difficult to 
obtain full matching for height. and this is reflected in the different average 
body height at baseline between patients and controls. However. controlling for 
body height in the analysis did not materially influence the results. The findings 
suggest that high doses of exogenous estrogens strongly increase serum total 
cholesterol. triglycerides. and apolipoproteins. The magnitude of the effect. also 
compared to changes reported in longitudinal studies of lipoprotein cholesterol 
in random samples of peripubertal children.11 supports the view that the rela-
tionship is a causal one. 
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TABLE 1 
Clinical and laboratory data on patients and controls 
at the first and second visit 
First Visit 
Patients Reference a roup 
Age (yr) 11.9 :+: 1.4 11.9 :+: 1.0 
Height (em) 168.7 :+: 7.5 161.9 :+: 6.3# 
Weight (kg) 49.4 :+: 7. 0 49.7 :+: 7.9 
Quetelet (kg;m2 )* 17.3 :+: 1.8 18.9 :!: 2 .2@ 
Bone age (Tanner RUS) (yr l 11.9 :+: 1.0 12.6 :+: 1.2 
Triglycerides (mmol/L) 0.92 :+: 0.43 1. 25 :+: 0.66 
Total cholesterol (mmol/L) 4.53 :+: 0.4.8 4. 64 :!:. 0. 76 
Apo B (mg/dL) !:5.2 :+: 13.7 .:.2 • 6 :+: 9.7& 
Apo A-I (rng;d:.) 136.5 + 23 .... 119.9 :+: 13.1& 
Second Visit 
Age (yr} 
Height (em) 
Weight {kg) 
Quetelet {kg;m2 )* 
Bone age (Tanner RUS) (yr) 
Pat~ents 
12.5 + 1.4 
172.0 + 5.8 
56.6 + 5.2 
19.1 + 1.3 
Triglycerides (mmol/L) 1.89 + 0.78 
Total cholesterol (mmol/L) 5.63 + 0.93 
Ape 8 (mg/dL) 81.9 + 12.4 
Ape A-I (mg/dL) 197.9 + 20.3 
Ape A-II (mg/dL) 68.3 + 9.6 
Values are given as mean .±. SD 2 
• Quetelet index . weight/height 
# Signi::icantly different from patien':s 
@ Significantly di:t"ferent from patients 
& Significantly different from patients 
a 
' a 
' a f 
Student's T-test for unpaired observations 
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Reference qrouo 
12.9 + 1.1 
167.2 + 5.3 
55.5 + 10.8 
19.8 + 3.2 
13.6 + 1.0 
0.84. + 0.31 
css + 0.75 
.C.2.6 + 12.7 
124.4 + 19.9 
48.8 + 6.4 
rst ·.·isi t {p < 0. 01) 
rst visit lp < 0. OS I 
rst visit (p < 0. 0 01) 
TABLE 2 
Average increase between two measurements in total and 
cholesterol apolipoprotein levels in patients and controls 
Patients Controls p• 
Total cholesterol 0.99 :t: 0.2 0.01 :t: 0 .1 0.0007 
Triglyceride O.B :t: 0.2 -0.1 :t: 0.2 0.009 
Apolipoprotein A-I 59.3 :t: 5. 0 7.5 :t: 4.2 <0.00001 
Apolipoprotein A-II 12.0 :t: 3. 4 -0.3 :t: 1.3 0.005 
Apolipoprotein B 33.1 :. S.B -4.2 :t: 2.6 <0.00001 
Values are given as mean + SEM and are adjusted for differences 
between patients and controlS in initial height, body weight, age, lnci 
lioid fractions. 
*.Two-tailed p-value. 
The changes of the apo A-1 levels and apo A-ll levels are in the same di-
rection as those reported earlier in other groups of women.9•12·13 In one stu-
dy.14 apo A-n was not affected. The change in apo B is opposite to what has 
been reponed with other types of estrogen and/or smaller dosages. Determination 
of apo B is designed to exclude VLDL-particles. 10 but a certain contribution of 
particles with an intermediate size between VLDL and LDL cannot be excluded. 
EstradioL given orally. reduces LDL levels13 and has even been recommended 
as a therapeutic for postmenopausal hypercholesterolemia-' EE given in a dosage 
of 0.06 mg per day reduced LDL cholesterol levels in a postmenopausal female 
subject.'' 
Estrogens have a number of metabolic actions. which may oppose each other 
in their ultimate effect on LDL IeveJs. On the one hand. there is a stimulation 
of the LDL receptor activity16 and this would speed up the removal of LDL 
and apo B from the circulation. EE also stimulates the triglyceride synthesis in 
the Jiver17 and this may be accompanied by an increased influx of apo B (as 
the major apoprotein of Very Low Density Lipoproteins) in the circulation." 
Our data would point to a dominance of this second effect when large doses of 
EE are used. 
The main clinical relevance of changes in circulating lipids and apolipopro-
teins is their relation to cardiovascular risk. LDL and apo B are associated with 
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an increase in risk whereas HDL and apolipoproteins A-1 and A-ll are associated 
with a decrease. The ratio apo A-1/apo B has been reported as a good risk dis-
criminator. 4 In the present investigation this ratio remained almost constant 
(2.49 before EE and 2.41 on EE) and thus the beneficial and hartnful effects of 
large doses of estrogens given to young women may be in balance. 
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Summary 
The change in serum total and high density lipoprotein (HDL) cholesterol 
and its determinants were investigated in 596 Dutch children. initially aged 5-19 
years. The children were randomly selected from residents of two districts of 
the town of Zoetermeer. This paper is based on 398 children (217 boys) who 
had at least three annual measurements of total cholesterol between 1975 and 
1985. The stability of a child's position in the distribution of serum lipids over 
time ('tracking') was studied by correlating the initial level with subsequent 
levels of serum lipids. Tracking correlations for total cholesterol after six years 
amounted to about 0. 7 in boys and 0.5 in girls. For HDL cholesterol these figures 
were 0.5 in boys and 0.4 in girls. To investigate the determinants of change in 
serum lipids. the rate of change in total and HDL cholesterol was obtained by 
least-squares regression of serum lipids on time for each subject. Initial levels 
of total and HDL cholesterol were negatively associated with subsequent change 
in these serum lipids. even after adjustment for regression toward the mean. 
Parental history of heart disease was unrelated to the change in serum lipids 
in their children. Serum cholesterol in the mother was positively associated with 
the change in cholesterol in boys. Initial body mass index was positively related 
to change in serum total cholesterol in boys and to change in HDL cholesterol 
in girls. The change in weight. height and body mass index was negatively re-
lated to the change in HDL cholesterol in boys as well as in girls. Use of oral 
contraceptives was negatively associated with change in serum total cholesteroL 
These observations suggest that there is tracking of a moderate magnitude of 
serum lipids in childhood. They furthermore suggest that there is no 'horse-ra-
cing' of serum lipids early in life. 
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INTRODUCTION 
The determinants of the level of serum lipids in childhood have been inves-
tigated quite extensively in recent years. 1· 11 By contrast. the determinants of 
change of lipids in early life have only received limited attention. 
This paper reports a study of the natural history of serum lipids in child-
hood and of the determinants of change in total and HDL cholesterol in early 
life. We studied 596 Dutch children. initially aged 5-19 years. who were randomly 
selected from a general population and who had at least three annual measure-
ments of serum total cholesterol. 
SUBJECTS AND METHODS 
Population 
All residents aged 5-19 years of two districts of Zoetermeer. a suburban 
residential area of about 55.000 inhibitants in 1980. located near the Hague in 
the Netherlands. were invited to take part in a study of risk indicators for car-
diovascular disease between 1975 and 1979. as described elsewhereY·13 Out of 
5.670 eligible subjects. 4.649 (82 per cent) participated. A random sample of 
596 children (300 boys) was taken from those examined initially and these child-
ren were invited to yearly follow-up examinations. This paper is based on 398 
of them (67 per cent) in whom at least three annual measurements of serum 
total cholesterol were obtained. The children who were not taken into the pres-
ent analysis had essentially the same average levels of serum total cholesterol 
as those on which this report is based. The attrition of the cohort was largely 
due to migration. No intervention measures were taken. and all children received 
the same advice about life habits. 
Measurements 
During the yearly examinations body height (in em) and weight (in kg) were 
measured with the subjects wearing indoor clothes without shoes. Serum total 
cholesterol was measured with an automated enzymatic method. utilizing the 
colour reactions according to Kageyama. 14 Serum HDL cholesterol was also meas-
ured using an automated enzymatic method with colour reaction according to 
Trinder. after precipitation with phosphotungstate-Mi+ .15 As measurement of 
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HDL cholesterol was initated only in 1980, fewer data were available for this 
variable. The determinations of both total and HDL cholesterol were carried 
out in the laboratory of our department, which participates in the lipids stan-
dardisation program of the WHO Regional Lipid Reference Centre in Prague (Dr. 
D. Grafnetter). 
Each year the respondents completed a questionnaire on smoking habits. 
use of alcoholic beverages. and use of coffee. Girls were also asked about their 
menstrual history. pregnancy and use of oral contraceptives. 
Data analysis 
The analysis of the data comprised two elements. First. the stability of a 
child"s position in the distribution of serum lipids over time (sometimes referred 
to as 'tracking') was studied by correlating the initial lipid levels with subse-
quent levels. Second. the determinants of change in serum lipids were investi-
gated by performing multiple linear regression of the change in serum lipids on 
the determinants measured at the first examination. The change in serum lipids 
was estimated by least-squares linear regression of total or HDL cholesterol on 
time for each individual. This yielded a slope and an intercept. which served as 
measures of the individual rate of change and the estimated initial level of li-
pids. respectively. In the regression models of putative determinants on the rate 
of change in lipids. the initial level of the lipids was included and therefore 
the coefficients represent the effect of a determinant on the rate of change 
conditional on initial level. All anaiyses were based on values of serum lipids 
transformed to per centile values. 16 In a seperate analysis attention was focussed 
on the relation between the initial level of lipids and their subsequent change. 
A positive relation between initial level and change has been referred to as 
"horse-racing'. In this analysis the individual slopes were regressed on the inter-
cepts. This yielded a regression coefficient. which was corrected for regression 
toward the mean using the approach of Blomqvist.17 In this approach the ratio 
of the average residual variance of the estimated initial values on time and the 
variance of the individual regressions of serum lipids on time are used to obtain 
a maximum likelihood estimate of the true coefficient of regression of s1ope on 
initial level. The regression coefficients are presented with their standard errors 
for six categories of age and gender for total serum cholesterol, and four cate-
gories for HDL cholesterol. The analysis was performed on children with at least 
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three to a maximum of ten annual lipid measurements. An analysis restricted to 
those who had at least five annual measurements yielded essentially the same 
findings. 
RESULTS 
Stability of position 
Correlation coefficients of total serum cholesterol at the first exam;nation 
and of various annual follow-up examinations are given in table 1. The coeffi-
cients after six years rangec'. from 0.68 10 0.73 in boys. and from 0.33 to 0.51 
in girls. In table 2 the coefficients are presented for HDL cholesterol. After 
five years the coefficients were 0.42 to 0.56 in boys and 0.38 to 0.41 in girls. 
Change in serum lipids 
The average per centile rate of change in serum total and in HDL chole-
sterol are given in tables 3 and 4. In boys aged 5-14 years initially an average 
decrease in total cholesterol was observed. whereas in 15-19 year old boys and 
in girls aged 5-19 years an average rise in cholesterol was found. In ali age 
and gender categories there was an average fall in HDL cholesterol. 
Determinants of change 
Initial level The observed coefficients of regression of the individual slopes 
on the intercepts were negative for both total and HDL cholesterol in all age-
categories. This applied to boys as well as to girls. After adjustment for re-
gression to the mean. the coefficients remained negative (tables 5 and 6). 
Parenral characteristics A history of coronary heart disease in the parents 
was not associated with the rate of change of serum total and HDL cholesterol 
(tables 7 and 8). The level of serum cholesterol of the mother. measured at the 
occasion of the initial examination of the child. was positively related to change 
in cholesterol in boys. 
Anrftropometrical characteristics The initial level of body mass index was 
positively related to the rate of change of total cholesterol in boys (table 7). 
Initial body mass index was positively associated with HDL cholesterol in girls 
(table 8). The change in body weight and body mass index was unrelated to 
the change in total cholesterol (table 7). The change in body weight, height 
and body mass index was negatively related to the change in HDL cholesterol 
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Years 
TABLE 1 
Correlation coefficients of initial total cholesterol 
and one to six years of follo~-up for males and 
females in three categories of initial age 
of 
follow-up S-9 years 10-14 years 15-19 years 
!'lales 
1 
2 
3 
4 
5 
6 
Females 
1 
2 
3 
4 
5 
6 
Years of 
n-54 n=75 n-=87 
0.63 0.66 0.73 
0.64 0.66 0.71 
0.66 0.57 0.71 
0.61 0.65 0.67 
0.54 0.69 0.67 
0.68 0.65 0. 75 
n-49 n .. 71 n""52 
0.65 0.58 0.24 
0.40 0.61 0.30 
0.38 0.58 0.37 
0. 37 0. 5~ 0.34 
0.27 0.62 0.52 
0.33 0. 59 0.51 
TABLE 2 
Correlation coefficients of initial EDL cholesterol 
and one to five years of follo~-up for males and 
females in t~o age categories 
follow-up 5-14 years 15-19 years 
Males n•72 n-117 
1 0.47 0.56 
2 0.21 0. 54 
3 0.41 0.61 
4 0.39 0.56 
5 0.~2 0.56 
Females n-69 n-74 
1 0.39 0.47 
2 0.45 0.35 
3 0.46 0.33 
4 0.41 0.35 
5 0.41 0.38 
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in both boys and girls (table 8). 
Other characrerisrics Smoking habits measured at the first examination 
were positively related to the rate of change in total and HDL cholesterol in 
boys. but not in girls (tables 7 and 8). The use of oral contraceptives at the 
first examination was associated negatively with serum total cholesterol (table 
7). but not with HDL cholesterol (table 8). 
TABLE 3 
Ave=age change in total cholesterol {per cent/year) for males 
and females in three groups of initial age 
5-9 years 10-14 years 15-19 years 
Mean SE Mean SE Mean SE 
Males -0.26 0.48 -0.23 0. 45 0.89 0.40 
Females 0.60 0.65 1.25 0.46 1. 98 0.57 
TABLE 4 
Average change in HDL cholesterol (per cent/year) for males 
and females in two groups of initial age 
5-14 years 15-19 years 
Mean SE Mean SE 
Males -2.57 0.58 -1.98 0.48 
Females -0.07 0.66 -1.56 0.66 
TABLE 5 
Adjusted# coefficients of linear regression of rate of change of 
total cholesterol (in per cent;year) on initial level of total 
cholesterol (per cent) 
Age in years Males Females 
b SE b SE 
5-9 -0.02 0.02 -0.07 0.02 
10-14 -0.05 0.01 -0.04. 0.01 
15-19 -0.02 0.01 -0.05 0.02 
Total -0.03 0.01 -0.05 0.01 
# according to Blomqvist (17) 
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TABLE 6 
Adjusted# coefficients of linear regression of rate of change of HDL 
cholesterol (in percent/year) on initial level of HDL cholesterol 
(in per cent) 
Age in years 
5-14 
15-19 
Total 
b 
-0.09 
-0.08 
-0.08 
Males 
# according to Blomqvist (17) 
Females 
SE b SE 
0.02 -0.10 0. 01 
0.01 -0.10 0. 01 
0.01 -0.09 0.01 
TABLE 7 
Coefficients# of linear regression of rate of change of serum total 
cholesterol (per cent/year) on several determinants 
Males Females 
Determinant Mean SE Mean SE 
Heart disease 
parents 1. 692 1.191 -1.443 2.711 
Cholesterol father: -0.003 0.006 -0.005 0.008 
Cholesterol mother 0.014** 0.006 -0.001 0.008 
Initial weight I%) 0. 014* 0.008 0.011 0.011 
Ini<:.ial height It I 0. 0 03 0.008 -0.001 0.010 
Initial QI I% I 0.028*** 0.008 0.013 0. 010 
Weight slope ('Vyr) -0.006 0. 073 -0.124 0. 087 
Height slope ( 't/yr) -0.195** 0. 076 -0.074 0. 097 
QI slope ( ~/yr) 0. 016 0.070 -0.119 0. 087 
Initial smoking 1.168* 0.6t:O 1.169 0.763 
Initial DCC -6.044*** l. 511 
# adjusted for inital total cholesterol levels 
* p < 0.10 ** p < 0.05 *** p < 0.01 
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TABLE 8 
Coefficients# of linear regression of rate of change of HDL 
cholesterol (per cent/year) on several determinants 
Determinant 
Heart disease 
parents 
Initial weight (%) 
Initial height (%) 
Initial QI (%) 
Weight slope (%/yr) 
Height slope (%/yr) 
QI slope {%/yr) 
Initial smoking 
Initial DCC 
Males 
Mean 
-0.489 
0.003 
0. 008 
-O.OJS 
-0.230*** 
-0.179* 
-0.181** 
1.438* 
SE 
1. 676 
0.012 
0. 011 
0.012 
0.089 
0.114 
0.086 
0.80~ 
# adjusted for inital HDL cholesterol levels 
"' p < 0.10 ** p < 0.05 *~* p < 0.01 
DISCUSSION 
Females 
Mean SE 
-2.182 2.912 
0.027* 0. 014 
0.021 0. 014 
0.028** 0. 014 
-0.189* 0.108 
-0.246* 0.139 
-0.190* 0.106 
-0.981 0.980 
-1.751 1.232 
The determinants of the level of serum lipids in children have been studied 
extensively. Familial aggregation of serum total cholesterol has been repor-
ted.1-3 Anthropometrical characteristics1·4-8 as well as hormonal factors8- 11 
and life habits5·6·9·11 have been suggested to be associated with serum lipids 
in early life. 
This study presents evidence concerning the determinants of the change in 
serum lipids in children and young adults. We did not find a positive relation 
between initial level of serum lipids and their subsequent change. even after 
adjustment for regression toward the mean. This observation renders it unlikely 
that there is "horse-racing· of serum total and HDL cholesterol in the first de-
cades of life. The magnitude of the "tracking" coefficients for total cholesterol 
in our study is relatively large. and this agrees well with other reports. 18-23 
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The main correlates of change in total cholesterol in boys appear to be 
maternal cholesterol. initial body mass index and initial smoking habits. It re-
mains to be clarified to change in total cholesterol in girls. A main finding is 
that the change in body weight, height and body mass is negatively related to 
the change in HDL cholesterol in girls. 
In summary. these observations suggest that there is moderate tracking of 
serum lipids in early life. There is no evidence for horse-racing of serum lipids 
in childhood. Level and change in anthropometrical variables appear to be related 
to the change in serum total and HDL cholesterol. 
141 
REFERENCES 
Johnson BC. Epstein FH. Kjelsberg MO. Distributions and familial studies of 
blood pressure and serum cholesterol levels in a total community-Tecumseh. 
Michigan. J Chron Dis 1965:18:147-60. 
2 Feinleib M. Garrison RJ. Fabsitz R. et a!. The NHBLI Twin Study of 
cardiovascular disease risk factors: Methodology and summary of results. Am 
J Epidemiol 1977:106:284-95. 
3 Morrison JA. Kelly K. Horvitz R. et a!. Parent-offspring and sibling lipid 
and lipoprotein associations during and after sharing household environments: 
The Princeton School District Family Study. Metabolism 1977:31:158-66. 
4 Clarke RP. Merrow SB. Morse EH. Keyser DE. Interrelationships between 
plasma lipids. physical measurements. and body fatness of adolescents in Bur-
lington. Vermont. Am J Clin Nutr 1970:23:754-63. 
5 Orchard TJ. Rodgers M. Hedley AJ. Mitchell JRA. Serum lipids in a teenage 
population: geographic. seasonal and familial factors. lnt J Epidemiol !981: 
10:161-70. 
6 Donahue RP. Orchard TJ. Kuller LH. Drash AL. Lipids and lipoproteins in a 
young adult population. The Beaver County Lipid Study. Am J 'Epidemiol 
1985:122:458-67. 
7 Frerichs RR. Webber LS. Srinivasan SR. Berenson GS. Relation of serum lipids 
and lipoproteins to obesity and sexual maturiy in white and black children. 
Am J Epidemiol 1978:108:486-96. 
8 Laskarzewski PM. Morrison JA. Gutai J. Orchard T. Khoury PR. Glueck CJ. 
High and low density lipoprotein cholesterol in adolescent boys: relationships 
with endogenous testosterone. estradiol. and quetelet index. Metabolism 
1983:32:262-71. 
9 Morrison JA. Kelly K. Mellies M. et a!. Cigarette smoking. alcohol intake. 
and oral contraceptives: relationships to lipids and lipoproteins in adolescent 
school-children. Metabolism 1979:28:1166-70. 
10 Wallace RB. Hoover J. Barrett-Connor E. eta!. Altered plasma lipid and lipo-
protein levels associated with oral contraceptive and oestrogen use. Lancet 
1979:ii: I I I -5. 
1 I Webber LS. Hunter SM. Baugh JG. Srinivasan SR. Sklov MC. Berenson GS. 
142 
The interaction of cigarette smoking, oral contraceptive use, and 
cardiovascular risk factor variables in children: The Bogalusa Heart Study. 
Am J Public Health 1982:72:266-74. 
12 Hofman A. Valkenburg HA. Distrubution and determinants of blood pressure 
in freeliving children. In: Kesteloot H. Joossens JV. eds. Epidemiology of 
arterial blood pressure. The Hague: Martinus Nijhoff. 1980:99-117. 
13 Hofman A. Valkenburg HA. Determinants of change in blood pressure during 
childhood. Am J Epidemic! 1983:117:735-43. 
14 Van Gent CM. Van der Voort HA. De Bruijn AM. Klein F. Cholesterol 
determinations. A comparative study of methods with special reference to 
enzymatic procedures. Clio Chim Acta 1977:75:243-51. 
15 Burstein M. Scholnick HR. Morfin R. Rapid method for the isolation of 
lipoproteins from human serum by precipitation with polyanions. J Lipid res-
1970: II :583-95. 
16 Lauer RM. Clarke WR. Beaglehole R. Level. trend. and variability of blood 
pressure during childhood: The Muscatine Study. Circulation 1984:69:242-9. 
17 Blomqvist N. On the relation between change and initial value. JASA 
1977:72:746-9. 
18 Clarke WR. Schrott HG. Leaverton PE. Connor WE. Lauer RM. Tracking of 
blood lipids and blood pressures in school age children: The Muscatine Study. 
Circulation 1978:58:626-34. 
19 Laskarzewski P. Morrison JA. deGroot I. et al. Lipid and lipoprotein tracking 
in 108 children over a four-year period. Pediatrics 1979:64:584-91. 
20 Frerichs RR. Webber LS. Voors WA. Srinivasan SR. Berenson OS. Cardio-
vascular disease risk factor variables in children at two successive years-The 
Bogalusa Heart Study. J Chron Dis !979:32:251-62. 
21 Widhalm K. Strobl W. Westphal. Age dependency and tracking of serJm lipids 
and lipoproteins in healthy children aged 11-14 years. Atherosclerosis 
1981:38:189-96. 
22 Webber LS. Cresanta JL. Voors AW. Berenson OS. Tracking of cardiovascular 
disease risk factor variables in school-age children. J Cron Dis 1983:36:647-60. 
23 Freedman DS. Shear CL. Srinivasan SR. Webber LS. Berenson OS. Tracking 
of serum lipids and lipoproteins in children over an 8-year period: The Boga-
lusa Heart Study. Prev Med 1985;14:203-16. 
143 
Appendix 6 
[Preliminary Note] 
IS THE RATIO OF APO B/APO A-1 AN EARLY PREDICTOR 
OF CORONARY ATHEROSCLEROSIS? 
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Summary 
It is unknov.rn which lipoprotein in childhood is the best predictor of athero-
sclerosis later on in life. We measured serum triglycerides. total cholesterol, its 
subfractions (LDL. HDL. HDL,. HDL3) and apoproteins (A-1. A-11. B) in two 
groups of children. They were offspring of fathers who had severe coronary 
atherosclerosis or no coronary sclerosis. as determined by coronary angiography. 
Fasting blood lipids were measured in 49 children of fathers with severe sclero-
sis. and in 37 children of fathers without sclerosis. Sons of fathers with severe 
coronary atherosclerosis had higher levels of apo B and of the ratio apo B/apo 
A-1 than sons of fathers free of atherosclerosis. No differences in lipid levels 
in daughters were observed. These observations suggest that apolipoproteins 
play a part in early atherogenesis. They further indicate tbat it may be possible 
to detect children who have a high probability of developing severe coronary 
atherosclerosis later in life. 
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INTRODUCTION 
Serum lipids are strongly associated with manifest atherosclerosis in adults. 
but little is known about their role in early atherogenesis. In particular. it is 
not clear which serum lipid parameter is the best predictor in childhood of athe-
rosclerosis later on in life. although apolipoproteins have been suggested1 [Free-
dman. unpublished report]. As children of parents with coronary heart disease 
are at far greater risk of developing atherosclerotic diseases than children of 
parents without heart disease. 2 we investigated whether children of men with 
angiographically defined severe coronary atherosclerosis differ in serum lipid 
and (apo)lipoprotein concentrations from offspring of men without coronary athe-
rosclerosis. 
SUBJECTS AND METHODS 
All male patients under the age of 60. who were referred to the Cardiology 
department of the Zuiderziekenhuis hospital in Rotterdam for a first coronary 
angiography to evaluate angina pectoris from August 1983 to February 1985. 
were eligible for the study (n=360). The angiograms were clinically assessed3 
by one observer (HACMK) who had no knowledge of serum lipid proft.les. Two 
groups of patients were selected: (I) those with no coronary atherosclerosis 
(less than 20% stenosis). and (2) those with severe coronary sclerosis (at least 
3 vessels with over 70% stenosis). Excluded from the study were patients who 
had no children. suffered from diabetes mellitus. hypertension (defined as at 
least 1 year treatment with anti-hypertensive drugs). had lipid lowering medi-
cation. or were known to have cardiomyopathy or valvular defects. This left 29 
men with no coronary sclerosis and 35 with severe atherosclerosis. Their families 
were invited with their youngest son and/or daughter and 59 (92%) participated 
in the study. Twenty-seven families (with 23 sons and 14 daughters) of whom 
the father was free of coronary atherosclerosis and 32 families (with 29 sons 
and 20 daughters) of whom the father suffered from severe atherosclerosis were 
examined. The mean ages of the fathers were 54 and 50 years. for those with 
severe and no atherosclerosis. respectively. They did not differ in average 
weight. smoking habits. use of alcoholic beverages. or regular physical exercise. 
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Of the fathers with severe atherosclerosis 55% used beta-blocking medication, 
as compared to 15% in the fathers without sclerosis. The age distribution was 
very similar in both groups of children (range 6-36 years. mean 21.2 years). 
After an overnight fast all participants underwent an examination which included 
antecubital venipuncture of 30 ml blood. measurements of height and body-
weight. and a questionnaire on smoking habits, alcohol consumption, physical 
exercise and current medication. Triglycerides, total cholesterol and its subfrac-
tions were determined according to enzymatic methods (Boehringer Peridochrom 
and Monotest, respectively). after precipitation with polyvinylsulfate for LDL 
cholesteroL Mg"+ -phosphotungstate for HDL cholesterol and Mn2+ -heparin and 
dextransulfate for HDL cholesterol subtractions! Apolipoprotein A-1 and A-ll 
were determined by radial immunodiffusion' against specific antiserum. Mono-
specific antisera against human apolipoprotein A-1 and A-ll were respectively 
raised in goats (provided by Dr. L Havekes, Gaubius Institute, Leiden) and sheep 
(Boehringer Mannheim). Total apolipoprotein B was measured by quantitative 
immunoelectrophoresis according to Lauren. 6 as described earlier. 7 
Average lipid levels of the two groups of fathers. sons and daughters were 
compared. Students t-test for unpaired observations was used to assess statistical 
significance. 
RESULTS 
The table shows average concentrations of serum lipids and apolipoproteins 
in fathers with and without coronary atherosclerosis. and in their sons and daug-
hters. Levels of triglycerides, total and LDL cholesterol and apo B were signifi-
cantly higher in fathers with severe atherosclerosis than in fathers without scle-
rosis. whereas levels of HDL, HDL2 and HDL3 cholesterol, and levels of apopro-
teins A-1 and A-ll were significantly lower. In the sons. significant differences 
between the two groups were observed in levels of apo B (p=0.02) and the apo 
B/apo A-1 ratio (p=0.02). In fathers. the largest differences were observed in 
levels of triglycerides (a 65% difference) and in the ratio of apo B/apo A-1 (51% 
difference). In the sons the ratio of apo B/apo A-1 was 25% higher in the off-
spring of fathers with severe atherosclerosis. A separate analysis which adjusted 
for the small differences in age distribution did not materially affect the obser-
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TABLE 
Lipid levels (in mg/100 ml) in fathers With coronarv atheroscleroSiS 
(CAS+) and without coronarv atherosclerosis 
their sons and daughters 
(CAS-), and in 
Fathers Sons Daughters 
CAS+ CAS- CAS+ CAS- CAS+ CAS-
Number of subjects 29 27 29 23 20 14 
Age ,:!:. SD 54+6 50,:.9 22+6 20+7 23+6 20,:.6 
Triglyceride 226*"'* 137 113 100 103 110 
I 18 I 1121 1111 I 12 I I 10 I I 11 I 
Total cholesterol 282*** 245 217 197 209 205 
I 7 I I 8 I I 9 I 17 I 18 I I 11 I 
LDL cholesterol 215*** 175 146 128 140 135 
I 7 I I 7 I ( 9) I 8 I I 8 I 1121 
HDL cholesterol 38"'** 48 
" 
49 52 53 
I 1 I I 2 I I 1 I ( 2) I 2 I I 3 I 
HDL 2 cholesterol 5"'* 9 9 10 13 14 I 1 I I 1 I I 1 I I 1 I I 1 I I 2 I 
HDL 3 cholesterol 33** 38 38 39 39 38 I 1 I I 1 I I 1 I I 1 I I 1 I I 21 
Apoprotein A-I 136*"'* 158 151 152 164 176 
I 4 I { 5) I 41 I 4 I I 81 112 I 
Apoprotein A-II O• 48 46 45 48 48 
I 2 I I 2 I 11 I I 1 I I 21 I 21 
Apoprotein B 157*** 121 102* 84 97 97 
I 51 I 51 I 61 I 4 I I 61 I 9 I 
Apo B/apo A-I 1.18*** 0. 78 0.70* 0.56 0.63 0.59 
I 0. 051 I 0. 04 I I 0. 06 I I 0. 03 I I 0. 06 I I o. 07 I 
Values are means (+ S.E.M.) 
* p<O.OS, ** p<O.Ol, *"'* p<O.OOl. 
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ved differences. A discriminant analysis. in which the outcome variable was coro-
nary atherosclerosis in fathers and the independent variables included all lipid 
fractions. confirmed that in sons the apolipoprotein ratio was the best predictor 
of atherosclerosis in their fathers. In fathers themselves the best discriminator 
was the ratio of HDLILDL cholesteroL 
DISCUSSION 
These observations indicate that young men who are at high risk for coronary 
atherosclerosis may have increased ratios of serum apo B/apo A-1. The power 
of this ratio to discriminate between survivors of myocardial infarction and a 
control population has been demonstrated by Avogaro et a!.' However. Schmidt 
et al.9 found that the ratio of HDL/total cholesterol correlated better with angi-
ographic findings in male patients. In our study. the best discriminator in the 
fathers was the ratio of HDLILDL cholesterol, whereas in their sons it was the 
apo B/apo A-1 ratio. This might point to an early predictive, but not necessarily 
aetiological role for apolipoproteins. whereas HDL and LDL cholesterol levels 
might mainly be affected later on in life. In children. an early predictive role 
for apo B in coronary disease has been suggested by Sniderman et al 1 In their 
study the parents were selected when they had a myocardial infarction combined 
with elevated apo B levels. The higher levels of apo B. as observed in their 
offspring compared to control children. may suggest early prediction of coronary 
artery disease. but may also be due to familial aggregation of apolipoproteins. 
In contrast to the study of Sniderrnan et a!., our patients were not selected on 
their levels of plasma lipoproteins. Our findings closely agree with those of 
Freedman et a!. [unpublished data]. who showed higher apo B/apo A-1 ratios in 
offspring of fathers with myocardial infarction compared to children without 
paternal myocardial infarction. Apo B increases with age. but because of the 
similar age distributions this did not affect our findings. as was borne out by 
a separate multivariate analysis. 
The absence of an association in daughters is remarkable. but hard to explain. 
This finding agrees with Schmidt et a!Y who observed no difference in plasma 
lipoprotein levels between women with and without coronary atherosclerosis. In 
women atherosclerosis becomes evident later in life and its pathogenesis may 
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be different from that in men. We also did not observe differences in HDL cho-
lesterol levels between the two groups of sons or daughters. This is in contrast 
with findings of Pometta et al., 10·" who observed familial aggregation of HDL 
cholesterol levels in patients with myocardial infarction. 
It has been suggested that selection bias may occur in studies of angio-
phically defined coronary atherosclerosis.3 We applied very strict inclusion cri-
teria, and it is difficult to see how selection bias would have affected apolipo-
proteins only. However. we cannot fully rule out this possibility and therefore 
consider our findings preliminary. Our observations imply that persons at high 
coronary risk may perhaps be identified early in life. and they also suggest that 
apolipoproteins may be implicated in early atherogenesis. If these preliminary 
results are confirmed, intervention studies to alter the apo B/apo A-l ratio in 
early life may be initiated. 
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EP!LOOG 
Het schrijven van een proefschrift is meer dan louter bet maken van een 
verslag van een onderzoek. Voor mij is het. naast een stuk opleiding tot epide-
mioloog. ook een weerslag van de samenwerk.ing met en de steun van velen. Dit 
nawoord wil ik graag gebruiken om hen te bedanken. Allereerst mijn ouders, 
die mij in aile vrijheid hebben Iaten studeren en mij aile kans hebben gegeven 
om datgene te worden wat ik wilde. Dit boekje draag ik daarom graag aan hen 
op. 
Niet elke arts word! epidemioloog of denkt er zelfs maar aan die richting 
op te gaan. Voor mij was het Prof. F. Sturmans. die mij nog tijdens mijn studie 
geneeskunde enthousiast maakte voor het ·vak". lk ben hem daar nog steeds 
dankbaar voor. 
De epidemiologie heb ik in vele aspekten leren kennen binnen het Instituut 
Epidemiologie van de Erasmus Universiteit te Rotterdam. Een afdeling. die naar 
het idee van Prof. Hans Valkenburg, uitgerust is met een eigen laboratorium en 
komputerkonfiguratie. en dus ook met evenzoveei verschillende mensen. lk dank 
je. Hans. voor de sfeer die jij wist te scheppen en je stimulerende belangstel!ing 
voor zovele onderwerpen. 
Bert Hofman, jij was degene die mij bij binnenkomst en nog lang daama 
begeleidde. Heel vee! heb ik van je geleerd en het is mede dankzij jou dat dit 
boekje tot stand is gekomen. lk dank je voor aile enthousiaste 'duwen· in de 
goede richting. 
EpidemiologiSch onderzoek is niet aileen onderzoek betreffende velen, maar 
ook verricht door velen. Op het EPOZ-centrum in Zoetermeer waren het Joke 
Jansen. Riet Radder. Ria Rijneveldshoek. Carlie Valkenburg en Wilma Verbruggen 
die het veldwerk verrichtten. Ik dank jullie. niet aileen voor je inzet. maar ook 
voor de prettige manier waarop we samenwerkten. 
De afdeling in Rotterdam in haar geheel vormde een plezierige werkplek en 
ik dank jullie allen daarvoor. Een paar personen wil ik nog even apart noemen. 
De administratieve kant van het onderzoek werd verzorgd door Yolanda Bekker 
en Lilian Verwey. Bedankt voor de punktuele afwerking en met name Yolanda. 
bedankt voor je hulp bij menig tekstverwerkingsprobleem. niet in het laatst bij 
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dit proefschrift. 
In een onderzoek met cholesterol als onderwerp kan een Jaboratorium niet 
anders dan een vooraanstaande rol spelen. Frank Klein. met je onnavolgbaar 
gevoel voor humor en je kritische zin was je een welkome steun bij aile overleg. 
Ton de Bruijn. in jou zijn vele talenten verenigd, waar ik dankbaar gebruik 
van heb gemaakt. In de laatste jaren kwarnen er een aantal nieuwe bepalingen 
bij. die vakbekwaam door Rene Vermeeren en Jeannette Drop werden uitgevoerd. 
De laatste fase van onderzoek is de analyse waarbij een komputer onmisbaar 
is. evenals de mensen die haar bedienen en gebruikersvriendelijk maken. Bram 
van Laar. Leo Muller en Leo van Romunde zijn daar wonderwel in geslaagd en 
ik dank hen daarvoor hartelijk. Leo Muller, het aantal keren dat ik jou gevraagd 
heb 'iets uit de komputer te hal en· hebben we niet bijgehouden. maar een extra 
woord van dank is hier zeker op zijn plaats. 
Voor de duizend en een dingen die geregeld moesten worden, kon altijd een 
beroep gedaan worden op het sekretariaat. Cilia Kuynders en Irene Borst. dank 
jullie we! voor al!es wat je gedaan hebt. 
Mijn (ex)karnergenoten. Rick Grobbee en Stella de Man. dank ik voor het 
aanhoren en bekommentarH!ren van alles wat op de kamer ter sprake werd ge-
bracht. 
Op het gebied van het cholesterolmetabolisme heb ik vee! geleerd van Pieter 
Groot. lk dank je voor je aanwijzingen en kommentaren. 
Het grafisch aspekt van het onderzoek kon met een gerust hart uit handen 
gegeven worden aan de altijd even vriendelijke en vakbekwame Cor van Dijk 
(Audio Visueel Centrum). 
Zoals gezegd. epidemiologisch onderzoek betreft veel mensen. Zonder respon-
denten evenwel zou onderzoek niet mogelijk zijn. Op deze plaats wil ik al de-
genen. die aan het onderzoek hebben meegedaan. bedanken. Speciaal gaat mijn 
dank uit naar de respondenten van het EPOZ onderzoek. die jaarlijks het cen-
trum bezochten en ons een schat aan inforrnatie hebben gegeven. 
Tenslotte dank ik mijn vrienden en vriendinnen voor hun belangstelling en 
oppeppende woorden. En Jos. de jou zo eigen bijdrage is moeilijk in woorden 
uit te drukken. maar is me daarom niet minder dierbaar. 
!53 

About the author 
Willy-Anne van Stiphout was born on November 21. 1956 in Breda. the Nether-
lands. After she graduated from secondary school at the Mencia de Mendoza 
Lyceum in 1975. she attended medical school at the Catholic University in 
Nijmegen. During the last year of her medical training she was initiated in 
epidemiology by Prof. F. Sturmans (former head of the department of Social 
Medicine) at the same university. She obtained her medical degree in October 
I 982. In February 1983 she started an in service training in epidemiology as a 
scientific research worker. at the department of Epidemiology (head: Prof. H.A. 
Valkenburg). of the Erasmus University in Rotterdam. Here she worked on the 
material that is set out in this thesis. She is a fellow of the Council on 
Epidemiology and Prevention of the International Society and Federation of 
Cardiology. She is a member of the European Society of Cardiology. Working 
Group on Epidemiology and Prevention. 
!55 



